{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bd2bebce",
   "metadata": {},
   "outputs": [],
   "source": [
    "# librerie\n",
    "import os\n",
    "import torch\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "from torch.utils.data import DataLoader, TensorDataset\n",
    "from sklearn.metrics import classification_report, confusion_matrix\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from tqdm import tqdm\n",
    "import torch.nn as nn\n",
    "import torch.optim as optim\n",
    "import random\n",
    "from sklearn.model_selection import StratifiedKFold\n",
    "from sklearn.metrics import precision_score, recall_score, f1_score"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0d9daeea",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<torch._C.Generator at 0x1ff7f2163d0>"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# riproducibilit√†\n",
    "random.seed(42)\n",
    "np.random.seed(42)\n",
    "torch.manual_seed(42)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "b0dfc643",
   "metadata": {},
   "outputs": [],
   "source": [
    "# configurazione\n",
    "image_size = 224 # dimensione a cui ridimensionare ogni immagine\n",
    "batch_size = 32  # batch size per i DataLoader\n",
    "n_components = 2342 # componenti principali che spiegano l 95% della soglia\n",
    "noise_std = 0.05\n",
    "# valori diversi di noise_std provati [0.0, 0.01, 0.05, 0.1, 0.2, 0.3]\n",
    "train_ratio, val_ratio = 0.7, 0.15  # percentuali per suddividere in train/val/test\n",
    "epochs = 100 # epoche training\n",
    "\n",
    "pretty_labels = ['adenocarcinoma', 'beigno', 'carcinoma squamoso']  # nomi delle classi pi√π leggibili"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a349f7a5",
   "metadata": {},
   "outputs": [],
   "source": [
    "# percorsi utili\n",
    "base_dir = os.getcwd()  # percorso base\n",
    "# percorso per salvare output\n",
    "output_folder = os.path.join(base_dir, \"pca_outputs\")\n",
    "os.makedirs(output_folder, exist_ok=True) # crea se non esiste\n",
    "log_txt_path = os.path.join(output_folder, \"classification_reports.txt\")\n",
    "save_path = os.path.join(output_folder, f'pca_data_{n_components}_{noise_std}.pth')\n",
    "experiment_name = os.path.splitext(os.path.basename(save_path))[0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "2bd8bf7c",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\giken\\AppData\\Local\\Temp\\ipykernel_9692\\743344398.py:4: UserWarning: To copy construct from a tensor, it is recommended to use sourceTensor.clone().detach() or sourceTensor.clone().detach().requires_grad_(True), rather than torch.tensor(sourceTensor).\n",
      "  y_train = torch.tensor(data_dict['train_labels'], dtype=torch.long)\n"
     ]
    }
   ],
   "source": [
    "# caricamento dati\n",
    "data_dict = torch.load(save_path, weights_only=False) # dati pre-elaborati (PCA) salvati in precedenza\n",
    "X_train = torch.tensor(data_dict['train_data'], dtype=torch.float32)\n",
    "y_train = torch.tensor(data_dict['train_labels'], dtype=torch.long)\n",
    "X_val = torch.tensor(data_dict['val_data'], dtype=torch.float32)\n",
    "y_val = torch.tensor(data_dict['val_labels'], dtype=torch.long)\n",
    "X_test = torch.tensor(data_dict['test_data'], dtype=torch.float32)\n",
    "y_test = torch.tensor(data_dict['test_labels'], dtype=torch.long)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "e6fa1f5c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# data_loaders\n",
    "train_loader = DataLoader(TensorDataset(X_train, y_train), batch_size=batch_size, shuffle=True)\n",
    "val_loader = DataLoader(TensorDataset(X_val, y_val), batch_size=batch_size)\n",
    "test_loader = DataLoader(TensorDataset(X_test, y_test), batch_size=batch_size)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5e9f38c9",
   "metadata": {},
   "outputs": [],
   "source": [
    "# modello flessibile\n",
    "class FlexibleNet(nn.Module):  # rete neurale FC, configurabile (layer, dropout, batchnorm)\n",
    "    def __init__(self, input_dim, hidden_dims, output_dim, use_batchnorm=False, dropout=0.0):\n",
    "        super().__init__()\n",
    "        layers = []\n",
    "        last_dim = input_dim\n",
    "        for hidden_dim in hidden_dims:\n",
    "            layers.append(nn.Linear(last_dim, hidden_dim))\n",
    "            if use_batchnorm:\n",
    "                layers.append(nn.BatchNorm1d(hidden_dim))\n",
    "            layers.append(nn.ReLU())\n",
    "            if dropout > 0:\n",
    "                layers.append(nn.Dropout(dropout))\n",
    "            last_dim = hidden_dim\n",
    "        layers.append(nn.Linear(last_dim, output_dim))\n",
    "        self.model = nn.Sequential(*layers)\n",
    "\n",
    "    def forward(self, x):\n",
    "        return self.model(x)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5b2aab7c",
   "metadata": {},
   "outputs": [],
   "source": [
    "def specificity_score(y_true, y_pred, average='macro'):\n",
    "    cm = confusion_matrix(y_true, y_pred)\n",
    "    num_classes = cm.shape[0]\n",
    "    specificities = []\n",
    "\n",
    "    for i in range(num_classes):\n",
    "        TP = cm[i, i]\n",
    "        FP = cm[:, i].sum() - TP\n",
    "        FN = cm[i, :].sum() - TP\n",
    "        TN = cm.sum() - (TP + FP + FN)\n",
    "        specificity = TN / (TN + FP) if (TN + FP) > 0 else 0.0\n",
    "        specificities.append(specificity)\n",
    "\n",
    "    if average == 'macro':\n",
    "        return np.mean(specificities)\n",
    "    elif average == 'none':\n",
    "        return specificities\n",
    "    else:\n",
    "        raise ValueError(\"average must be 'macro' or 'none'\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "f3b4d4c8",
   "metadata": {},
   "outputs": [],
   "source": [
    "# funzione di training\n",
    "def train_model(model, train_loader, val_loader, criterion, optimizer, use_early_stopping=True, patience=10):\n",
    "    best_val_loss = float('inf')\n",
    "    trigger_times = 0\n",
    "    history = {'train_acc': [], 'val_acc': []}\n",
    "\n",
    "    for epoch in range(epochs):\n",
    "        model.train()\n",
    "        correct, total = 0, 0\n",
    "        for X_batch, y_batch in train_loader:\n",
    "            optimizer.zero_grad()\n",
    "            output = model(X_batch)\n",
    "            loss = criterion(output, y_batch)\n",
    "            loss.backward()\n",
    "            optimizer.step()\n",
    "            correct += (output.argmax(1) == y_batch).sum().item()\n",
    "            total += y_batch.size(0)\n",
    "        train_acc = 100 * correct / total\n",
    "\n",
    "        model.eval()\n",
    "        val_correct, val_total = 0, 0\n",
    "        val_loss = 0\n",
    "        with torch.no_grad():\n",
    "            for X_batch, y_batch in val_loader:\n",
    "                output = model(X_batch)\n",
    "                loss = criterion(output, y_batch)\n",
    "                val_loss += loss.item()\n",
    "                val_correct += (output.argmax(1) == y_batch).sum().item()\n",
    "                val_total += y_batch.size(0)\n",
    "        val_acc = 100 * val_correct / val_total\n",
    "\n",
    "        history['train_acc'].append(train_acc)\n",
    "        history['val_acc'].append(val_acc)\n",
    "\n",
    "        print(f\"Epoch {epoch+1:02d} | Train Acc: {train_acc:.2f}% | Val Acc: {val_acc:.2f}%\")\n",
    "\n",
    "        if use_early_stopping:\n",
    "            if val_loss < best_val_loss:\n",
    "                best_val_loss = val_loss\n",
    "                trigger_times = 0\n",
    "                best_model_state = model.state_dict()\n",
    "            else:\n",
    "                trigger_times += 1\n",
    "                if trigger_times >= patience:\n",
    "                    print(\"Early stopping triggered.\")\n",
    "                    break\n",
    "\n",
    "    if use_early_stopping:\n",
    "        model.load_state_dict(best_model_state)\n",
    "    return model, history"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "d9a4d7ac",
   "metadata": {},
   "outputs": [],
   "source": [
    "results = []\n",
    "summary = []\n",
    "\n",
    "# funzione di cross-validation\n",
    "def cross_validate_model(config, X_data, y_data, k=5, config_id=None):\n",
    "    print(f\"\\nüîÅ Cross-validation model: {config}\")\n",
    "    skf = StratifiedKFold(n_splits=k, shuffle=True, random_state=42)\n",
    "    fold_accuracies = []\n",
    "    all_y_true, all_y_pred = [], []\n",
    "\n",
    "    for fold, (train_idx, val_idx) in enumerate(skf.split(X_data, y_data), 1):\n",
    "        print(f\"\\nüìÇ Fold {fold}/{k}\")\n",
    "        X_train_cv, y_train_cv = X_data[train_idx], y_data[train_idx]\n",
    "        X_val_cv, y_val_cv = X_data[val_idx], y_data[val_idx]\n",
    "\n",
    "        train_loader_cv = DataLoader(TensorDataset(X_train_cv, y_train_cv), batch_size=batch_size, shuffle=True)\n",
    "        val_loader_cv = DataLoader(TensorDataset(X_val_cv, y_val_cv), batch_size=batch_size)\n",
    "\n",
    "        model = FlexibleNet(n_components, config['hidden_dims'], len(pretty_labels),\n",
    "                            use_batchnorm=config['batchnorm'], dropout=config['dropout'])\n",
    "        criterion = nn.CrossEntropyLoss()\n",
    "        optimizer = optim.Adam(model.parameters(), lr=0.001, weight_decay=1e-4)\n",
    "\n",
    "        model, _ = train_model(model, train_loader_cv, val_loader_cv, criterion, optimizer,\n",
    "                               use_early_stopping=config['early_stopping'])\n",
    "\n",
    "        model.eval()\n",
    "        y_true_fold, y_pred_fold = [], []\n",
    "        with torch.no_grad():\n",
    "            for X_batch, y_batch in val_loader_cv:\n",
    "                output = model(X_batch)\n",
    "                preds = output.argmax(1)\n",
    "                y_true_fold.extend(y_batch.tolist())\n",
    "                y_pred_fold.extend(preds.tolist())\n",
    "\n",
    "        acc = 100 * np.mean(np.array(y_true_fold) == np.array(y_pred_fold))\n",
    "        fold_accuracies.append(acc)\n",
    "        all_y_true.extend(y_true_fold)\n",
    "        all_y_pred.extend(y_pred_fold)\n",
    "\n",
    "        report_fold = classification_report(y_true_fold, y_pred_fold, target_names=pretty_labels)\n",
    "        print(f\"Fold {fold} Accuracy: {acc:.2f}%\")\n",
    "        print(report_fold)\n",
    "\n",
    "        fold_title = f\"[{experiment_name}] Config {config_id} - Fold {fold}\"\n",
    "        with open(log_txt_path, \"a\") as f:\n",
    "            f.write(f\"{fold_title}\\n{report_fold}\\n\")\n",
    "            f.write(f\"Fold Accuracy: {acc:.2f}%\\n\")\n",
    "            f.write(\"-\" * 80 + \"\\n\")\n",
    "\n",
    "    mean_acc = np.mean(fold_accuracies)\n",
    "    std_acc = np.std(fold_accuracies)\n",
    "\n",
    "    precision = precision_score(all_y_true, all_y_pred, average='macro')\n",
    "    recall = recall_score(all_y_true, all_y_pred, average='macro')\n",
    "    f1 = f1_score(all_y_true, all_y_pred, average='macro')\n",
    "    specificity_macro = specificity_score(all_y_true, all_y_pred)\n",
    "\n",
    "    final_title = f\"[{experiment_name}] Config {config_id} - SUMMARY\"\n",
    "    with open(log_txt_path, \"a\") as f:\n",
    "        f.write(f\"{final_title}\\n\")\n",
    "        f.write(f\"Mean Fold Accuracy: {mean_acc:.2f}% ¬± {std_acc:.2f}\\n\")\n",
    "        f.write(\"=\" * 100 + \"\\n\")\n",
    "\n",
    "    print(f\"\\n‚úÖ Config {config_id} - CV Mean Accuracy: {mean_acc:.2f}% ¬± {std_acc:.2f}%\")\n",
    "\n",
    "    cumulative_cm = confusion_matrix(all_y_true, all_y_pred)\n",
    "    plt.figure(figsize=(8, 6))\n",
    "    sns.heatmap(cumulative_cm, annot=True, fmt='d',\n",
    "                xticklabels=pretty_labels,\n",
    "                yticklabels=pretty_labels,\n",
    "                cmap='Blues')\n",
    "    plt.title(\"Confusion Matrix cumulativa\")\n",
    "    plt.xlabel('Predicted')\n",
    "    plt.ylabel('True')\n",
    "    plt.tight_layout()\n",
    "    cumulative_path = os.path.join(output_folder, f\"{experiment_name}_conf_matrix_cumulative_config_{config_id}.png\")\n",
    "    plt.savefig(cumulative_path)\n",
    "    plt.close()\n",
    "\n",
    "    summary.append({\n",
    "        'config_id': config_id,\n",
    "        'hidden_dims': config['hidden_dims'],\n",
    "        'dropout': config['dropout'],\n",
    "        'batchnorm': config['batchnorm'],\n",
    "        'early_stopping': config['early_stopping'],\n",
    "        'cross_val': True,\n",
    "        'accuracy': mean_acc,\n",
    "        'precision': precision,\n",
    "        'recall': recall,\n",
    "        'f1_score': f1,\n",
    "        'specificity': specificity_macro,\n",
    "        'conf_matrix': cumulative_cm.tolist()\n",
    "    })\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "6200c39f",
   "metadata": {},
   "outputs": [],
   "source": [
    "configurations = [\n",
    "    {'hidden_dims': [64], 'batchnorm': False, 'dropout': 0.0, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [128], 'batchnorm': False, 'dropout': 0.1, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [128, 64], 'batchnorm': False, 'dropout': 0.3, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [128, 64], 'batchnorm': True, 'dropout': 0.3, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [256, 128], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [512, 256, 128], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [512, 256, 128], 'batchnorm': True, 'dropout': 0.7, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256, 128], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.7, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256, 128, 64, 32], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256, 128, 64, 32], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256, 128, 64, 32], 'batchnorm': True, 'dropout': 0.7, 'early_stopping': True, 'cross_val': True},\n",
    "    {'hidden_dims': [1024, 512, 256, 128, 64, 32, 16], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True},\n",
    "]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "cca041d8",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "[pca_data_2342_0.05] Config 1: {'hidden_dims': [64], 'batchnorm': False, 'dropout': 0.0, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [64], 'batchnorm': False, 'dropout': 0.0, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 67.25% | Val Acc: 71.02%\n",
      "Epoch 02 | Train Acc: 85.03% | Val Acc: 71.26%\n",
      "Epoch 03 | Train Acc: 91.14% | Val Acc: 72.46%\n",
      "Epoch 04 | Train Acc: 94.77% | Val Acc: 72.23%\n",
      "Epoch 05 | Train Acc: 96.92% | Val Acc: 71.88%\n",
      "Epoch 06 | Train Acc: 95.93% | Val Acc: 71.37%\n",
      "Epoch 07 | Train Acc: 95.67% | Val Acc: 68.89%\n",
      "Epoch 08 | Train Acc: 97.16% | Val Acc: 71.72%\n",
      "Epoch 09 | Train Acc: 99.24% | Val Acc: 71.68%\n",
      "Epoch 10 | Train Acc: 99.89% | Val Acc: 71.96%\n",
      "Epoch 11 | Train Acc: 100.00% | Val Acc: 71.92%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 71.92%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.62      0.62      0.62       861\n",
      "           benigno       0.87      0.89      0.88       855\n",
      "carcinoma squamoso       0.66      0.65      0.65       862\n",
      "\n",
      "          accuracy                           0.72      2578\n",
      "         macro avg       0.72      0.72      0.72      2578\n",
      "      weighted avg       0.72      0.72      0.72      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 67.45% | Val Acc: 70.09%\n",
      "Epoch 02 | Train Acc: 84.11% | Val Acc: 70.75%\n",
      "Epoch 03 | Train Acc: 89.91% | Val Acc: 69.71%\n",
      "Epoch 04 | Train Acc: 94.71% | Val Acc: 70.48%\n",
      "Epoch 05 | Train Acc: 96.47% | Val Acc: 70.67%\n",
      "Epoch 06 | Train Acc: 96.25% | Val Acc: 69.82%\n",
      "Epoch 07 | Train Acc: 96.83% | Val Acc: 69.78%\n",
      "Epoch 08 | Train Acc: 98.58% | Val Acc: 70.40%\n",
      "Epoch 09 | Train Acc: 99.03% | Val Acc: 69.59%\n",
      "Epoch 10 | Train Acc: 99.17% | Val Acc: 70.64%\n",
      "Epoch 11 | Train Acc: 98.70% | Val Acc: 70.83%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 70.83%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.62      0.61      0.61       861\n",
      "           benigno       0.86      0.90      0.88       855\n",
      "carcinoma squamoso       0.64      0.62      0.63       862\n",
      "\n",
      "          accuracy                           0.71      2578\n",
      "         macro avg       0.71      0.71      0.71      2578\n",
      "      weighted avg       0.71      0.71      0.71      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 67.21% | Val Acc: 71.10%\n",
      "Epoch 02 | Train Acc: 83.83% | Val Acc: 70.71%\n",
      "Epoch 03 | Train Acc: 90.55% | Val Acc: 70.99%\n",
      "Epoch 04 | Train Acc: 94.84% | Val Acc: 70.52%\n",
      "Epoch 05 | Train Acc: 96.48% | Val Acc: 70.05%\n",
      "Epoch 06 | Train Acc: 96.63% | Val Acc: 70.48%\n",
      "Epoch 07 | Train Acc: 96.02% | Val Acc: 70.99%\n",
      "Epoch 08 | Train Acc: 97.83% | Val Acc: 71.80%\n",
      "Epoch 09 | Train Acc: 99.04% | Val Acc: 71.49%\n",
      "Epoch 10 | Train Acc: 99.65% | Val Acc: 71.96%\n",
      "Epoch 11 | Train Acc: 99.97% | Val Acc: 71.49%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 71.49%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.60      0.62      0.61       862\n",
      "           benigno       0.88      0.90      0.89       854\n",
      "carcinoma squamoso       0.67      0.62      0.64       862\n",
      "\n",
      "          accuracy                           0.71      2578\n",
      "         macro avg       0.71      0.72      0.71      2578\n",
      "      weighted avg       0.71      0.71      0.71      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 67.80% | Val Acc: 71.36%\n",
      "Epoch 02 | Train Acc: 84.19% | Val Acc: 71.71%\n",
      "Epoch 03 | Train Acc: 90.06% | Val Acc: 72.25%\n",
      "Epoch 04 | Train Acc: 94.05% | Val Acc: 72.06%\n",
      "Epoch 05 | Train Acc: 96.35% | Val Acc: 71.32%\n",
      "Epoch 06 | Train Acc: 96.17% | Val Acc: 71.87%\n",
      "Epoch 07 | Train Acc: 96.98% | Val Acc: 71.63%\n",
      "Epoch 08 | Train Acc: 97.49% | Val Acc: 71.56%\n",
      "Epoch 09 | Train Acc: 98.60% | Val Acc: 72.88%\n",
      "Epoch 10 | Train Acc: 99.52% | Val Acc: 72.84%\n",
      "Epoch 11 | Train Acc: 99.70% | Val Acc: 72.14%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 72.14%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.63      0.63      0.63       862\n",
      "           benigno       0.87      0.90      0.88       854\n",
      "carcinoma squamoso       0.66      0.63      0.64       861\n",
      "\n",
      "          accuracy                           0.72      2577\n",
      "         macro avg       0.72      0.72      0.72      2577\n",
      "      weighted avg       0.72      0.72      0.72      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 67.61% | Val Acc: 70.90%\n",
      "Epoch 02 | Train Acc: 85.16% | Val Acc: 70.62%\n",
      "Epoch 03 | Train Acc: 90.96% | Val Acc: 70.00%\n",
      "Epoch 04 | Train Acc: 94.81% | Val Acc: 71.40%\n",
      "Epoch 05 | Train Acc: 96.48% | Val Acc: 71.01%\n",
      "Epoch 06 | Train Acc: 95.25% | Val Acc: 70.20%\n",
      "Epoch 07 | Train Acc: 96.29% | Val Acc: 70.90%\n",
      "Epoch 08 | Train Acc: 98.21% | Val Acc: 71.13%\n",
      "Epoch 09 | Train Acc: 99.34% | Val Acc: 71.91%\n",
      "Epoch 10 | Train Acc: 99.90% | Val Acc: 71.25%\n",
      "Epoch 11 | Train Acc: 100.00% | Val Acc: 71.63%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 71.63%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.62      0.58      0.60       862\n",
      "           benigno       0.88      0.90      0.89       854\n",
      "carcinoma squamoso       0.64      0.67      0.65       861\n",
      "\n",
      "          accuracy                           0.72      2577\n",
      "         macro avg       0.71      0.72      0.72      2577\n",
      "      weighted avg       0.71      0.72      0.71      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 1 - CV Mean Accuracy: 71.60% ¬± 0.45%\n",
      "\n",
      "[pca_data_2342_0.05] Config 2: {'hidden_dims': [128], 'batchnorm': False, 'dropout': 0.1, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [128], 'batchnorm': False, 'dropout': 0.1, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 67.51% | Val Acc: 72.42%\n",
      "Epoch 02 | Train Acc: 83.37% | Val Acc: 72.23%\n",
      "Epoch 03 | Train Acc: 89.77% | Val Acc: 72.11%\n",
      "Epoch 04 | Train Acc: 92.74% | Val Acc: 73.27%\n",
      "Epoch 05 | Train Acc: 94.95% | Val Acc: 71.68%\n",
      "Epoch 06 | Train Acc: 95.08% | Val Acc: 73.04%\n",
      "Epoch 07 | Train Acc: 96.27% | Val Acc: 72.11%\n",
      "Epoch 08 | Train Acc: 97.60% | Val Acc: 72.92%\n",
      "Epoch 09 | Train Acc: 97.99% | Val Acc: 73.20%\n",
      "Epoch 10 | Train Acc: 97.77% | Val Acc: 72.77%\n",
      "Epoch 11 | Train Acc: 96.84% | Val Acc: 71.26%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 71.26%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.65      0.54      0.59       861\n",
      "           benigno       0.86      0.89      0.87       855\n",
      "carcinoma squamoso       0.63      0.71      0.66       862\n",
      "\n",
      "          accuracy                           0.71      2578\n",
      "         macro avg       0.71      0.71      0.71      2578\n",
      "      weighted avg       0.71      0.71      0.71      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 67.93% | Val Acc: 71.02%\n",
      "Epoch 02 | Train Acc: 83.22% | Val Acc: 71.02%\n",
      "Epoch 03 | Train Acc: 89.60% | Val Acc: 69.94%\n",
      "Epoch 04 | Train Acc: 92.74% | Val Acc: 69.67%\n",
      "Epoch 05 | Train Acc: 94.99% | Val Acc: 72.19%\n",
      "Epoch 06 | Train Acc: 95.78% | Val Acc: 70.79%\n",
      "Epoch 07 | Train Acc: 95.90% | Val Acc: 71.14%\n",
      "Epoch 08 | Train Acc: 96.60% | Val Acc: 72.07%\n",
      "Epoch 09 | Train Acc: 97.33% | Val Acc: 71.37%\n",
      "Epoch 10 | Train Acc: 97.62% | Val Acc: 71.26%\n",
      "Epoch 11 | Train Acc: 98.02% | Val Acc: 71.14%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 71.14%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.61      0.63      0.62       861\n",
      "           benigno       0.86      0.89      0.88       855\n",
      "carcinoma squamoso       0.65      0.61      0.63       862\n",
      "\n",
      "          accuracy                           0.71      2578\n",
      "         macro avg       0.71      0.71      0.71      2578\n",
      "      weighted avg       0.71      0.71      0.71      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 67.77% | Val Acc: 71.61%\n",
      "Epoch 02 | Train Acc: 83.50% | Val Acc: 71.06%\n",
      "Epoch 03 | Train Acc: 89.74% | Val Acc: 71.53%\n",
      "Epoch 04 | Train Acc: 92.77% | Val Acc: 71.96%\n",
      "Epoch 05 | Train Acc: 93.84% | Val Acc: 72.23%\n",
      "Epoch 06 | Train Acc: 95.79% | Val Acc: 72.58%\n",
      "Epoch 07 | Train Acc: 96.34% | Val Acc: 70.83%\n",
      "Epoch 08 | Train Acc: 96.84% | Val Acc: 71.64%\n",
      "Epoch 09 | Train Acc: 97.67% | Val Acc: 71.45%\n",
      "Epoch 10 | Train Acc: 98.00% | Val Acc: 71.33%\n",
      "Epoch 11 | Train Acc: 96.99% | Val Acc: 72.19%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 72.19%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.64      0.60      0.62       862\n",
      "           benigno       0.87      0.90      0.88       854\n",
      "carcinoma squamoso       0.65      0.66      0.66       862\n",
      "\n",
      "          accuracy                           0.72      2578\n",
      "         macro avg       0.72      0.72      0.72      2578\n",
      "      weighted avg       0.72      0.72      0.72      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 67.19% | Val Acc: 71.63%\n",
      "Epoch 02 | Train Acc: 83.27% | Val Acc: 73.15%\n",
      "Epoch 03 | Train Acc: 89.51% | Val Acc: 73.65%\n",
      "Epoch 04 | Train Acc: 93.17% | Val Acc: 73.42%\n",
      "Epoch 05 | Train Acc: 94.31% | Val Acc: 73.69%\n",
      "Epoch 06 | Train Acc: 94.16% | Val Acc: 73.61%\n",
      "Epoch 07 | Train Acc: 97.07% | Val Acc: 73.96%\n",
      "Epoch 08 | Train Acc: 97.92% | Val Acc: 73.42%\n",
      "Epoch 09 | Train Acc: 97.12% | Val Acc: 71.94%\n",
      "Epoch 10 | Train Acc: 97.56% | Val Acc: 73.34%\n",
      "Epoch 11 | Train Acc: 97.11% | Val Acc: 72.68%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 72.68%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.63      0.66      0.64       862\n",
      "           benigno       0.88      0.89      0.89       854\n",
      "carcinoma squamoso       0.67      0.63      0.65       861\n",
      "\n",
      "          accuracy                           0.73      2577\n",
      "         macro avg       0.73      0.73      0.73      2577\n",
      "      weighted avg       0.73      0.73      0.73      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 67.70% | Val Acc: 71.91%\n",
      "Epoch 02 | Train Acc: 84.44% | Val Acc: 71.63%\n",
      "Epoch 03 | Train Acc: 90.35% | Val Acc: 71.28%\n",
      "Epoch 04 | Train Acc: 92.76% | Val Acc: 72.25%\n",
      "Epoch 05 | Train Acc: 94.22% | Val Acc: 71.91%\n",
      "Epoch 06 | Train Acc: 95.76% | Val Acc: 72.68%\n",
      "Epoch 07 | Train Acc: 95.77% | Val Acc: 70.43%\n",
      "Epoch 08 | Train Acc: 96.53% | Val Acc: 71.13%\n",
      "Epoch 09 | Train Acc: 97.80% | Val Acc: 72.02%\n",
      "Epoch 10 | Train Acc: 97.77% | Val Acc: 71.67%\n",
      "Epoch 11 | Train Acc: 97.28% | Val Acc: 71.94%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 71.94%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.62      0.59      0.60       862\n",
      "           benigno       0.87      0.91      0.89       854\n",
      "carcinoma squamoso       0.66      0.66      0.66       861\n",
      "\n",
      "          accuracy                           0.72      2577\n",
      "         macro avg       0.72      0.72      0.72      2577\n",
      "      weighted avg       0.72      0.72      0.72      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 2 - CV Mean Accuracy: 71.84% ¬± 0.58%\n",
      "\n",
      "[pca_data_2342_0.05] Config 3: {'hidden_dims': [128, 64], 'batchnorm': False, 'dropout': 0.3, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [128, 64], 'batchnorm': False, 'dropout': 0.3, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 66.17% | Val Acc: 73.04%\n",
      "Epoch 02 | Train Acc: 77.27% | Val Acc: 73.97%\n",
      "Epoch 03 | Train Acc: 82.57% | Val Acc: 72.38%\n",
      "Epoch 04 | Train Acc: 86.19% | Val Acc: 73.04%\n",
      "Epoch 05 | Train Acc: 88.93% | Val Acc: 72.96%\n",
      "Epoch 06 | Train Acc: 91.17% | Val Acc: 74.52%\n",
      "Epoch 07 | Train Acc: 92.36% | Val Acc: 73.89%\n",
      "Epoch 08 | Train Acc: 93.52% | Val Acc: 72.07%\n",
      "Epoch 09 | Train Acc: 94.51% | Val Acc: 73.89%\n",
      "Epoch 10 | Train Acc: 95.12% | Val Acc: 74.48%\n",
      "Epoch 11 | Train Acc: 95.82% | Val Acc: 74.17%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 74.17%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.63      0.65       861\n",
      "           benigno       0.86      0.93      0.89       855\n",
      "carcinoma squamoso       0.68      0.67      0.68       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 66.71% | Val Acc: 70.48%\n",
      "Epoch 02 | Train Acc: 77.16% | Val Acc: 71.33%\n",
      "Epoch 03 | Train Acc: 82.32% | Val Acc: 69.63%\n",
      "Epoch 04 | Train Acc: 86.15% | Val Acc: 71.10%\n",
      "Epoch 05 | Train Acc: 89.05% | Val Acc: 71.96%\n",
      "Epoch 06 | Train Acc: 90.50% | Val Acc: 71.02%\n",
      "Epoch 07 | Train Acc: 92.53% | Val Acc: 70.75%\n",
      "Epoch 08 | Train Acc: 93.22% | Val Acc: 70.44%\n",
      "Epoch 09 | Train Acc: 94.23% | Val Acc: 71.14%\n",
      "Epoch 10 | Train Acc: 94.84% | Val Acc: 69.08%\n",
      "Epoch 11 | Train Acc: 95.30% | Val Acc: 70.48%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 70.48%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.60      0.62      0.61       861\n",
      "           benigno       0.86      0.90      0.88       855\n",
      "carcinoma squamoso       0.65      0.60      0.62       862\n",
      "\n",
      "          accuracy                           0.70      2578\n",
      "         macro avg       0.70      0.71      0.70      2578\n",
      "      weighted avg       0.70      0.70      0.70      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 66.36% | Val Acc: 71.72%\n",
      "Epoch 02 | Train Acc: 77.76% | Val Acc: 72.38%\n",
      "Epoch 03 | Train Acc: 81.93% | Val Acc: 71.41%\n",
      "Epoch 04 | Train Acc: 85.65% | Val Acc: 73.04%\n",
      "Epoch 05 | Train Acc: 88.08% | Val Acc: 72.15%\n",
      "Epoch 06 | Train Acc: 90.07% | Val Acc: 73.12%\n",
      "Epoch 07 | Train Acc: 91.69% | Val Acc: 73.35%\n",
      "Epoch 08 | Train Acc: 93.06% | Val Acc: 72.85%\n",
      "Epoch 09 | Train Acc: 93.86% | Val Acc: 73.12%\n",
      "Epoch 10 | Train Acc: 95.31% | Val Acc: 73.16%\n",
      "Epoch 11 | Train Acc: 95.14% | Val Acc: 73.04%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 73.04%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.62      0.69      0.65       862\n",
      "           benigno       0.88      0.92      0.90       854\n",
      "carcinoma squamoso       0.69      0.58      0.63       862\n",
      "\n",
      "          accuracy                           0.73      2578\n",
      "         macro avg       0.73      0.73      0.73      2578\n",
      "      weighted avg       0.73      0.73      0.73      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 66.48% | Val Acc: 72.18%\n",
      "Epoch 02 | Train Acc: 76.75% | Val Acc: 73.46%\n",
      "Epoch 03 | Train Acc: 82.03% | Val Acc: 74.04%\n",
      "Epoch 04 | Train Acc: 85.48% | Val Acc: 73.54%\n",
      "Epoch 05 | Train Acc: 88.18% | Val Acc: 73.61%\n",
      "Epoch 06 | Train Acc: 89.93% | Val Acc: 73.96%\n",
      "Epoch 07 | Train Acc: 92.37% | Val Acc: 73.77%\n",
      "Epoch 08 | Train Acc: 93.42% | Val Acc: 73.42%\n",
      "Epoch 09 | Train Acc: 94.05% | Val Acc: 73.69%\n",
      "Epoch 10 | Train Acc: 94.77% | Val Acc: 74.47%\n",
      "Epoch 11 | Train Acc: 95.24% | Val Acc: 73.22%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 73.22%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.59      0.62       862\n",
      "           benigno       0.88      0.91      0.90       854\n",
      "carcinoma squamoso       0.65      0.69      0.67       861\n",
      "\n",
      "          accuracy                           0.73      2577\n",
      "         macro avg       0.73      0.73      0.73      2577\n",
      "      weighted avg       0.73      0.73      0.73      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 65.85% | Val Acc: 71.52%\n",
      "Epoch 02 | Train Acc: 77.23% | Val Acc: 72.88%\n",
      "Epoch 03 | Train Acc: 82.81% | Val Acc: 73.03%\n",
      "Epoch 04 | Train Acc: 85.46% | Val Acc: 72.56%\n",
      "Epoch 05 | Train Acc: 88.50% | Val Acc: 71.79%\n",
      "Epoch 06 | Train Acc: 90.46% | Val Acc: 71.94%\n",
      "Epoch 07 | Train Acc: 91.91% | Val Acc: 72.53%\n",
      "Epoch 08 | Train Acc: 93.10% | Val Acc: 71.59%\n",
      "Epoch 09 | Train Acc: 94.32% | Val Acc: 72.53%\n",
      "Epoch 10 | Train Acc: 94.48% | Val Acc: 71.98%\n",
      "Epoch 11 | Train Acc: 95.35% | Val Acc: 72.22%\n",
      "Epoch 12 | Train Acc: 96.14% | Val Acc: 72.06%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 72.06%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.63      0.60      0.62       862\n",
      "           benigno       0.88      0.92      0.90       854\n",
      "carcinoma squamoso       0.64      0.64      0.64       861\n",
      "\n",
      "          accuracy                           0.72      2577\n",
      "         macro avg       0.72      0.72      0.72      2577\n",
      "      weighted avg       0.72      0.72      0.72      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 3 - CV Mean Accuracy: 72.59% ¬± 1.25%\n",
      "\n",
      "[pca_data_2342_0.05] Config 4: {'hidden_dims': [128, 64], 'batchnorm': True, 'dropout': 0.3, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [128, 64], 'batchnorm': True, 'dropout': 0.3, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 66.29% | Val Acc: 73.12%\n",
      "Epoch 02 | Train Acc: 76.45% | Val Acc: 72.92%\n",
      "Epoch 03 | Train Acc: 82.19% | Val Acc: 73.82%\n",
      "Epoch 04 | Train Acc: 85.65% | Val Acc: 74.13%\n",
      "Epoch 05 | Train Acc: 87.86% | Val Acc: 73.55%\n",
      "Epoch 06 | Train Acc: 90.34% | Val Acc: 73.62%\n",
      "Epoch 07 | Train Acc: 91.61% | Val Acc: 75.29%\n",
      "Epoch 08 | Train Acc: 92.78% | Val Acc: 74.86%\n",
      "Epoch 09 | Train Acc: 93.73% | Val Acc: 74.05%\n",
      "Epoch 10 | Train Acc: 94.50% | Val Acc: 74.63%\n",
      "Epoch 11 | Train Acc: 95.28% | Val Acc: 74.67%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 74.67%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.64      0.65       861\n",
      "           benigno       0.89      0.92      0.91       855\n",
      "carcinoma squamoso       0.68      0.68      0.68       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.74      0.75      0.75      2578\n",
      "      weighted avg       0.74      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 66.23% | Val Acc: 71.61%\n",
      "Epoch 02 | Train Acc: 77.01% | Val Acc: 71.37%\n",
      "Epoch 03 | Train Acc: 81.43% | Val Acc: 72.07%\n",
      "Epoch 04 | Train Acc: 85.23% | Val Acc: 71.18%\n",
      "Epoch 05 | Train Acc: 87.85% | Val Acc: 71.57%\n",
      "Epoch 06 | Train Acc: 89.49% | Val Acc: 72.54%\n",
      "Epoch 07 | Train Acc: 91.82% | Val Acc: 72.11%\n",
      "Epoch 08 | Train Acc: 92.96% | Val Acc: 72.42%\n",
      "Epoch 09 | Train Acc: 93.84% | Val Acc: 73.00%\n",
      "Epoch 10 | Train Acc: 94.21% | Val Acc: 71.99%\n",
      "Epoch 11 | Train Acc: 94.74% | Val Acc: 72.50%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 72.50%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.64      0.60      0.62       861\n",
      "           benigno       0.87      0.91      0.89       855\n",
      "carcinoma squamoso       0.66      0.67      0.67       862\n",
      "\n",
      "          accuracy                           0.72      2578\n",
      "         macro avg       0.72      0.73      0.72      2578\n",
      "      weighted avg       0.72      0.72      0.72      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 66.48% | Val Acc: 73.04%\n",
      "Epoch 02 | Train Acc: 77.23% | Val Acc: 72.15%\n",
      "Epoch 03 | Train Acc: 81.60% | Val Acc: 71.92%\n",
      "Epoch 04 | Train Acc: 84.45% | Val Acc: 72.77%\n",
      "Epoch 05 | Train Acc: 87.85% | Val Acc: 72.07%\n",
      "Epoch 06 | Train Acc: 90.00% | Val Acc: 72.65%\n",
      "Epoch 07 | Train Acc: 92.03% | Val Acc: 72.92%\n",
      "Epoch 08 | Train Acc: 92.92% | Val Acc: 72.61%\n",
      "Epoch 09 | Train Acc: 93.49% | Val Acc: 72.30%\n",
      "Epoch 10 | Train Acc: 94.46% | Val Acc: 73.24%\n",
      "Epoch 11 | Train Acc: 95.00% | Val Acc: 73.78%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 73.78%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.64      0.65      0.64       862\n",
      "           benigno       0.90      0.88      0.89       854\n",
      "carcinoma squamoso       0.68      0.69      0.69       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 66.80% | Val Acc: 72.60%\n",
      "Epoch 02 | Train Acc: 76.90% | Val Acc: 73.34%\n",
      "Epoch 03 | Train Acc: 81.14% | Val Acc: 72.88%\n",
      "Epoch 04 | Train Acc: 84.84% | Val Acc: 73.85%\n",
      "Epoch 05 | Train Acc: 88.31% | Val Acc: 74.58%\n",
      "Epoch 06 | Train Acc: 90.09% | Val Acc: 73.15%\n",
      "Epoch 07 | Train Acc: 91.49% | Val Acc: 73.73%\n",
      "Epoch 08 | Train Acc: 92.67% | Val Acc: 75.36%\n",
      "Epoch 09 | Train Acc: 93.77% | Val Acc: 73.46%\n",
      "Epoch 10 | Train Acc: 94.62% | Val Acc: 74.12%\n",
      "Epoch 11 | Train Acc: 94.95% | Val Acc: 74.19%\n",
      "Epoch 12 | Train Acc: 95.66% | Val Acc: 74.93%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 74.93%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.68      0.63      0.65       862\n",
      "           benigno       0.89      0.91      0.90       854\n",
      "carcinoma squamoso       0.68      0.71      0.70       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 67.17% | Val Acc: 71.44%\n",
      "Epoch 02 | Train Acc: 77.08% | Val Acc: 71.67%\n",
      "Epoch 03 | Train Acc: 82.20% | Val Acc: 71.01%\n",
      "Epoch 04 | Train Acc: 85.84% | Val Acc: 71.75%\n",
      "Epoch 05 | Train Acc: 87.86% | Val Acc: 71.98%\n",
      "Epoch 06 | Train Acc: 89.77% | Val Acc: 72.72%\n",
      "Epoch 07 | Train Acc: 91.87% | Val Acc: 72.72%\n",
      "Epoch 08 | Train Acc: 93.01% | Val Acc: 73.03%\n",
      "Epoch 09 | Train Acc: 94.23% | Val Acc: 73.34%\n",
      "Epoch 10 | Train Acc: 94.45% | Val Acc: 72.14%\n",
      "Epoch 11 | Train Acc: 94.89% | Val Acc: 72.80%\n",
      "Epoch 12 | Train Acc: 95.62% | Val Acc: 72.84%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 72.84%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.65      0.57      0.61       862\n",
      "           benigno       0.86      0.92      0.89       854\n",
      "carcinoma squamoso       0.66      0.70      0.67       861\n",
      "\n",
      "          accuracy                           0.73      2577\n",
      "         macro avg       0.72      0.73      0.73      2577\n",
      "      weighted avg       0.72      0.73      0.72      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 4 - CV Mean Accuracy: 73.74% ¬± 0.96%\n",
      "\n",
      "[pca_data_2342_0.05] Config 5: {'hidden_dims': [256, 128], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [256, 128], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 65.72% | Val Acc: 72.81%\n",
      "Epoch 02 | Train Acc: 74.83% | Val Acc: 73.74%\n",
      "Epoch 03 | Train Acc: 79.59% | Val Acc: 73.00%\n",
      "Epoch 04 | Train Acc: 82.73% | Val Acc: 74.79%\n",
      "Epoch 05 | Train Acc: 85.75% | Val Acc: 74.17%\n",
      "Epoch 06 | Train Acc: 87.33% | Val Acc: 73.89%\n",
      "Epoch 07 | Train Acc: 88.55% | Val Acc: 74.40%\n",
      "Epoch 08 | Train Acc: 90.86% | Val Acc: 74.98%\n",
      "Epoch 09 | Train Acc: 92.14% | Val Acc: 73.89%\n",
      "Epoch 10 | Train Acc: 92.45% | Val Acc: 74.20%\n",
      "Epoch 11 | Train Acc: 93.68% | Val Acc: 74.94%\n",
      "Epoch 12 | Train Acc: 94.07% | Val Acc: 73.78%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 73.78%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.60      0.63       861\n",
      "           benigno       0.91      0.88      0.89       855\n",
      "carcinoma squamoso       0.65      0.73      0.69       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 66.05% | Val Acc: 72.23%\n",
      "Epoch 02 | Train Acc: 75.90% | Val Acc: 71.61%\n",
      "Epoch 03 | Train Acc: 79.58% | Val Acc: 72.23%\n",
      "Epoch 04 | Train Acc: 83.58% | Val Acc: 71.30%\n",
      "Epoch 05 | Train Acc: 85.75% | Val Acc: 71.99%\n",
      "Epoch 06 | Train Acc: 87.85% | Val Acc: 71.99%\n",
      "Epoch 07 | Train Acc: 89.43% | Val Acc: 71.80%\n",
      "Epoch 08 | Train Acc: 91.16% | Val Acc: 72.73%\n",
      "Epoch 09 | Train Acc: 91.94% | Val Acc: 73.43%\n",
      "Epoch 10 | Train Acc: 92.41% | Val Acc: 72.92%\n",
      "Epoch 11 | Train Acc: 93.47% | Val Acc: 73.66%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 73.66%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.59      0.62       861\n",
      "           benigno       0.86      0.93      0.89       855\n",
      "carcinoma squamoso       0.66      0.70      0.68       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.73      0.74      0.73      2578\n",
      "      weighted avg       0.73      0.74      0.73      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 65.73% | Val Acc: 71.06%\n",
      "Epoch 02 | Train Acc: 76.37% | Val Acc: 72.19%\n",
      "Epoch 03 | Train Acc: 79.76% | Val Acc: 72.77%\n",
      "Epoch 04 | Train Acc: 82.51% | Val Acc: 73.31%\n",
      "Epoch 05 | Train Acc: 85.32% | Val Acc: 72.77%\n",
      "Epoch 06 | Train Acc: 86.96% | Val Acc: 72.85%\n",
      "Epoch 07 | Train Acc: 88.74% | Val Acc: 73.39%\n",
      "Epoch 08 | Train Acc: 89.98% | Val Acc: 73.70%\n",
      "Epoch 09 | Train Acc: 91.69% | Val Acc: 74.48%\n",
      "Epoch 10 | Train Acc: 91.56% | Val Acc: 73.31%\n",
      "Epoch 11 | Train Acc: 93.07% | Val Acc: 73.31%\n",
      "Epoch 12 | Train Acc: 93.97% | Val Acc: 73.93%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 73.93%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.63      0.67      0.65       862\n",
      "           benigno       0.88      0.91      0.89       854\n",
      "carcinoma squamoso       0.70      0.64      0.67       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 66.36% | Val Acc: 72.53%\n",
      "Epoch 02 | Train Acc: 74.86% | Val Acc: 71.48%\n",
      "Epoch 03 | Train Acc: 78.94% | Val Acc: 72.45%\n",
      "Epoch 04 | Train Acc: 81.98% | Val Acc: 73.38%\n",
      "Epoch 05 | Train Acc: 85.33% | Val Acc: 74.19%\n",
      "Epoch 06 | Train Acc: 87.03% | Val Acc: 74.97%\n",
      "Epoch 07 | Train Acc: 88.99% | Val Acc: 73.88%\n",
      "Epoch 08 | Train Acc: 90.40% | Val Acc: 73.92%\n",
      "Epoch 09 | Train Acc: 90.83% | Val Acc: 74.89%\n",
      "Epoch 10 | Train Acc: 92.94% | Val Acc: 74.89%\n",
      "Epoch 11 | Train Acc: 92.96% | Val Acc: 75.36%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 75.36%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.61      0.65       862\n",
      "           benigno       0.89      0.93      0.91       854\n",
      "carcinoma squamoso       0.68      0.73      0.70       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 65.59% | Val Acc: 71.91%\n",
      "Epoch 02 | Train Acc: 75.40% | Val Acc: 73.07%\n",
      "Epoch 03 | Train Acc: 79.13% | Val Acc: 72.56%\n",
      "Epoch 04 | Train Acc: 82.23% | Val Acc: 71.91%\n",
      "Epoch 05 | Train Acc: 85.37% | Val Acc: 72.53%\n",
      "Epoch 06 | Train Acc: 87.74% | Val Acc: 73.50%\n",
      "Epoch 07 | Train Acc: 89.08% | Val Acc: 73.50%\n",
      "Epoch 08 | Train Acc: 90.63% | Val Acc: 73.34%\n",
      "Epoch 09 | Train Acc: 91.77% | Val Acc: 74.00%\n",
      "Epoch 10 | Train Acc: 92.24% | Val Acc: 74.00%\n",
      "Epoch 11 | Train Acc: 92.96% | Val Acc: 74.27%\n",
      "Epoch 12 | Train Acc: 93.95% | Val Acc: 73.88%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 73.88%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.57      0.61       862\n",
      "           benigno       0.90      0.93      0.92       854\n",
      "carcinoma squamoso       0.65      0.72      0.68       861\n",
      "\n",
      "          accuracy                           0.74      2577\n",
      "         macro avg       0.74      0.74      0.74      2577\n",
      "      weighted avg       0.74      0.74      0.74      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 5 - CV Mean Accuracy: 74.12% ¬± 0.62%\n",
      "\n",
      "[pca_data_2342_0.05] Config 6: {'hidden_dims': [512, 256, 128], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [512, 256, 128], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 64.94% | Val Acc: 72.61%\n",
      "Epoch 02 | Train Acc: 75.05% | Val Acc: 73.39%\n",
      "Epoch 03 | Train Acc: 79.05% | Val Acc: 73.47%\n",
      "Epoch 04 | Train Acc: 83.26% | Val Acc: 73.47%\n",
      "Epoch 05 | Train Acc: 85.49% | Val Acc: 74.32%\n",
      "Epoch 06 | Train Acc: 87.36% | Val Acc: 74.05%\n",
      "Epoch 07 | Train Acc: 89.17% | Val Acc: 74.59%\n",
      "Epoch 08 | Train Acc: 90.32% | Val Acc: 74.44%\n",
      "Epoch 09 | Train Acc: 91.77% | Val Acc: 74.75%\n",
      "Epoch 10 | Train Acc: 93.24% | Val Acc: 75.76%\n",
      "Epoch 11 | Train Acc: 93.52% | Val Acc: 73.89%\n",
      "Epoch 12 | Train Acc: 93.89% | Val Acc: 76.18%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 76.18%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.65      0.67       861\n",
      "           benigno       0.90      0.91      0.90       855\n",
      "carcinoma squamoso       0.70      0.73      0.71       862\n",
      "\n",
      "          accuracy                           0.76      2578\n",
      "         macro avg       0.76      0.76      0.76      2578\n",
      "      weighted avg       0.76      0.76      0.76      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 65.02% | Val Acc: 71.06%\n",
      "Epoch 02 | Train Acc: 74.64% | Val Acc: 70.99%\n",
      "Epoch 03 | Train Acc: 79.09% | Val Acc: 71.96%\n",
      "Epoch 04 | Train Acc: 83.29% | Val Acc: 71.92%\n",
      "Epoch 05 | Train Acc: 85.54% | Val Acc: 72.23%\n",
      "Epoch 06 | Train Acc: 87.57% | Val Acc: 72.92%\n",
      "Epoch 07 | Train Acc: 88.71% | Val Acc: 72.15%\n",
      "Epoch 08 | Train Acc: 91.03% | Val Acc: 72.65%\n",
      "Epoch 09 | Train Acc: 91.47% | Val Acc: 72.85%\n",
      "Epoch 10 | Train Acc: 92.27% | Val Acc: 72.61%\n",
      "Epoch 11 | Train Acc: 93.27% | Val Acc: 72.96%\n",
      "Epoch 12 | Train Acc: 93.61% | Val Acc: 73.86%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 73.86%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.65      0.64      0.65       861\n",
      "           benigno       0.92      0.87      0.90       855\n",
      "carcinoma squamoso       0.66      0.70      0.68       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 65.29% | Val Acc: 71.41%\n",
      "Epoch 02 | Train Acc: 74.74% | Val Acc: 72.73%\n",
      "Epoch 03 | Train Acc: 79.69% | Val Acc: 73.16%\n",
      "Epoch 04 | Train Acc: 82.42% | Val Acc: 73.74%\n",
      "Epoch 05 | Train Acc: 85.57% | Val Acc: 73.47%\n",
      "Epoch 06 | Train Acc: 87.61% | Val Acc: 75.06%\n",
      "Epoch 07 | Train Acc: 89.39% | Val Acc: 73.62%\n",
      "Epoch 08 | Train Acc: 90.48% | Val Acc: 73.82%\n",
      "Epoch 09 | Train Acc: 92.06% | Val Acc: 74.28%\n",
      "Epoch 10 | Train Acc: 91.91% | Val Acc: 73.58%\n",
      "Epoch 11 | Train Acc: 93.67% | Val Acc: 74.36%\n",
      "Epoch 12 | Train Acc: 94.03% | Val Acc: 73.89%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 73.89%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.58      0.62       862\n",
      "           benigno       0.94      0.87      0.90       854\n",
      "carcinoma squamoso       0.65      0.77      0.70       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.75      0.74      0.74      2578\n",
      "      weighted avg       0.75      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 64.41% | Val Acc: 73.46%\n",
      "Epoch 02 | Train Acc: 75.14% | Val Acc: 70.86%\n",
      "Epoch 03 | Train Acc: 79.17% | Val Acc: 73.46%\n",
      "Epoch 04 | Train Acc: 82.56% | Val Acc: 74.93%\n",
      "Epoch 05 | Train Acc: 85.06% | Val Acc: 74.47%\n",
      "Epoch 06 | Train Acc: 87.77% | Val Acc: 74.93%\n",
      "Epoch 07 | Train Acc: 88.80% | Val Acc: 74.78%\n",
      "Epoch 08 | Train Acc: 90.84% | Val Acc: 74.31%\n",
      "Epoch 09 | Train Acc: 92.04% | Val Acc: 74.12%\n",
      "Epoch 10 | Train Acc: 92.38% | Val Acc: 74.23%\n",
      "Epoch 11 | Train Acc: 93.49% | Val Acc: 75.28%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 75.28%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.66      0.66       862\n",
      "           benigno       0.90      0.90      0.90       854\n",
      "carcinoma squamoso       0.69      0.69      0.69       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 65.27% | Val Acc: 72.53%\n",
      "Epoch 02 | Train Acc: 75.41% | Val Acc: 72.22%\n",
      "Epoch 03 | Train Acc: 79.85% | Val Acc: 72.49%\n",
      "Epoch 04 | Train Acc: 82.93% | Val Acc: 73.88%\n",
      "Epoch 05 | Train Acc: 85.77% | Val Acc: 73.30%\n",
      "Epoch 06 | Train Acc: 87.86% | Val Acc: 72.41%\n",
      "Epoch 07 | Train Acc: 89.65% | Val Acc: 73.34%\n",
      "Epoch 08 | Train Acc: 91.38% | Val Acc: 73.50%\n",
      "Epoch 09 | Train Acc: 92.42% | Val Acc: 73.81%\n",
      "Epoch 10 | Train Acc: 92.75% | Val Acc: 73.57%\n",
      "Epoch 11 | Train Acc: 93.02% | Val Acc: 74.08%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.08%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.54      0.60       862\n",
      "           benigno       0.87      0.95      0.91       854\n",
      "carcinoma squamoso       0.66      0.74      0.70       861\n",
      "\n",
      "          accuracy                           0.74      2577\n",
      "         macro avg       0.74      0.74      0.73      2577\n",
      "      weighted avg       0.74      0.74      0.73      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 6 - CV Mean Accuracy: 74.66% ¬± 0.92%\n",
      "\n",
      "[pca_data_2342_0.05] Config 7: {'hidden_dims': [512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 60.29% | Val Acc: 70.60%\n",
      "Epoch 02 | Train Acc: 72.10% | Val Acc: 73.58%\n",
      "Epoch 03 | Train Acc: 76.10% | Val Acc: 74.40%\n",
      "Epoch 04 | Train Acc: 79.77% | Val Acc: 73.12%\n",
      "Epoch 05 | Train Acc: 82.34% | Val Acc: 74.20%\n",
      "Epoch 06 | Train Acc: 85.50% | Val Acc: 73.70%\n",
      "Epoch 07 | Train Acc: 86.50% | Val Acc: 74.09%\n",
      "Epoch 08 | Train Acc: 88.37% | Val Acc: 75.64%\n",
      "Epoch 09 | Train Acc: 89.52% | Val Acc: 75.10%\n",
      "Epoch 10 | Train Acc: 91.03% | Val Acc: 75.17%\n",
      "Epoch 11 | Train Acc: 91.59% | Val Acc: 76.07%\n",
      "Epoch 12 | Train Acc: 92.98% | Val Acc: 75.25%\n",
      "Epoch 13 | Train Acc: 93.64% | Val Acc: 74.75%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 74.75%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.61      0.64       861\n",
      "           benigno       0.91      0.90      0.91       855\n",
      "carcinoma squamoso       0.66      0.73      0.70       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.75      0.75      0.75      2578\n",
      "      weighted avg       0.75      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 60.33% | Val Acc: 69.71%\n",
      "Epoch 02 | Train Acc: 72.26% | Val Acc: 72.46%\n",
      "Epoch 03 | Train Acc: 77.16% | Val Acc: 71.37%\n",
      "Epoch 04 | Train Acc: 79.76% | Val Acc: 72.81%\n",
      "Epoch 05 | Train Acc: 83.40% | Val Acc: 71.41%\n",
      "Epoch 06 | Train Acc: 85.27% | Val Acc: 72.54%\n",
      "Epoch 07 | Train Acc: 86.49% | Val Acc: 71.49%\n",
      "Epoch 08 | Train Acc: 88.20% | Val Acc: 71.37%\n",
      "Epoch 09 | Train Acc: 89.82% | Val Acc: 72.11%\n",
      "Epoch 10 | Train Acc: 91.23% | Val Acc: 73.86%\n",
      "Epoch 11 | Train Acc: 91.46% | Val Acc: 72.23%\n",
      "Epoch 12 | Train Acc: 92.64% | Val Acc: 73.78%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 73.78%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.61      0.64       861\n",
      "           benigno       0.87      0.91      0.89       855\n",
      "carcinoma squamoso       0.66      0.69      0.68       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.73      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 59.89% | Val Acc: 72.58%\n",
      "Epoch 02 | Train Acc: 71.79% | Val Acc: 73.35%\n",
      "Epoch 03 | Train Acc: 76.63% | Val Acc: 72.73%\n",
      "Epoch 04 | Train Acc: 79.88% | Val Acc: 73.47%\n",
      "Epoch 05 | Train Acc: 82.39% | Val Acc: 73.04%\n",
      "Epoch 06 | Train Acc: 84.58% | Val Acc: 74.59%\n",
      "Epoch 07 | Train Acc: 87.12% | Val Acc: 73.08%\n",
      "Epoch 08 | Train Acc: 88.64% | Val Acc: 74.17%\n",
      "Epoch 09 | Train Acc: 89.78% | Val Acc: 74.28%\n",
      "Epoch 10 | Train Acc: 90.98% | Val Acc: 73.08%\n",
      "Epoch 11 | Train Acc: 91.40% | Val Acc: 74.44%\n",
      "Epoch 12 | Train Acc: 92.57% | Val Acc: 74.98%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 74.98%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.65      0.67      0.66       862\n",
      "           benigno       0.92      0.89      0.90       854\n",
      "carcinoma squamoso       0.69      0.70      0.69       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.75      0.75      0.75      2578\n",
      "      weighted avg       0.75      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 59.38% | Val Acc: 69.31%\n",
      "Epoch 02 | Train Acc: 71.60% | Val Acc: 72.64%\n",
      "Epoch 03 | Train Acc: 76.30% | Val Acc: 73.50%\n",
      "Epoch 04 | Train Acc: 80.01% | Val Acc: 72.95%\n",
      "Epoch 05 | Train Acc: 81.99% | Val Acc: 74.08%\n",
      "Epoch 06 | Train Acc: 84.41% | Val Acc: 74.93%\n",
      "Epoch 07 | Train Acc: 86.37% | Val Acc: 74.35%\n",
      "Epoch 08 | Train Acc: 88.64% | Val Acc: 74.23%\n",
      "Epoch 09 | Train Acc: 90.01% | Val Acc: 75.09%\n",
      "Epoch 10 | Train Acc: 91.49% | Val Acc: 75.16%\n",
      "Epoch 11 | Train Acc: 91.42% | Val Acc: 75.05%\n",
      "Epoch 12 | Train Acc: 92.74% | Val Acc: 75.51%\n",
      "Epoch 13 | Train Acc: 92.97% | Val Acc: 75.36%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 75.36%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.68      0.65      0.66       862\n",
      "           benigno       0.88      0.92      0.90       854\n",
      "carcinoma squamoso       0.69      0.70      0.70       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 60.11% | Val Acc: 71.17%\n",
      "Epoch 02 | Train Acc: 71.58% | Val Acc: 71.63%\n",
      "Epoch 03 | Train Acc: 77.00% | Val Acc: 72.33%\n",
      "Epoch 04 | Train Acc: 80.12% | Val Acc: 71.98%\n",
      "Epoch 05 | Train Acc: 82.88% | Val Acc: 72.84%\n",
      "Epoch 06 | Train Acc: 84.96% | Val Acc: 71.98%\n",
      "Epoch 07 | Train Acc: 86.98% | Val Acc: 72.41%\n",
      "Epoch 08 | Train Acc: 88.78% | Val Acc: 72.60%\n",
      "Epoch 09 | Train Acc: 89.57% | Val Acc: 73.15%\n",
      "Epoch 10 | Train Acc: 91.00% | Val Acc: 73.77%\n",
      "Epoch 11 | Train Acc: 92.00% | Val Acc: 72.53%\n",
      "Epoch 12 | Train Acc: 92.48% | Val Acc: 73.07%\n",
      "Epoch 13 | Train Acc: 93.67% | Val Acc: 73.96%\n",
      "Epoch 14 | Train Acc: 93.63% | Val Acc: 74.47%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.47%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.62      0.64       862\n",
      "           benigno       0.91      0.90      0.91       854\n",
      "carcinoma squamoso       0.67      0.71      0.69       861\n",
      "\n",
      "          accuracy                           0.74      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.74      0.74      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 7 - CV Mean Accuracy: 74.67% ¬± 0.53%\n",
      "\n",
      "[pca_data_2342_0.05] Config 8: {'hidden_dims': [1024, 512, 256, 128], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [1024, 512, 256, 128], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 59.87% | Val Acc: 72.54%\n",
      "Epoch 02 | Train Acc: 71.78% | Val Acc: 73.55%\n",
      "Epoch 03 | Train Acc: 75.54% | Val Acc: 74.28%\n",
      "Epoch 04 | Train Acc: 79.42% | Val Acc: 73.58%\n",
      "Epoch 05 | Train Acc: 82.14% | Val Acc: 74.98%\n",
      "Epoch 06 | Train Acc: 84.16% | Val Acc: 74.17%\n",
      "Epoch 07 | Train Acc: 85.97% | Val Acc: 74.98%\n",
      "Epoch 08 | Train Acc: 87.84% | Val Acc: 74.79%\n",
      "Epoch 09 | Train Acc: 89.40% | Val Acc: 75.45%\n",
      "Epoch 10 | Train Acc: 90.14% | Val Acc: 74.86%\n",
      "Epoch 11 | Train Acc: 91.08% | Val Acc: 75.33%\n",
      "Epoch 12 | Train Acc: 91.99% | Val Acc: 75.48%\n",
      "Epoch 13 | Train Acc: 92.50% | Val Acc: 75.21%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 75.21%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.67      0.66       861\n",
      "           benigno       0.93      0.87      0.90       855\n",
      "carcinoma squamoso       0.68      0.71      0.70       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.76      0.75      0.75      2578\n",
      "      weighted avg       0.76      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 60.65% | Val Acc: 71.06%\n",
      "Epoch 02 | Train Acc: 71.94% | Val Acc: 71.96%\n",
      "Epoch 03 | Train Acc: 76.38% | Val Acc: 71.14%\n",
      "Epoch 04 | Train Acc: 80.00% | Val Acc: 72.58%\n",
      "Epoch 05 | Train Acc: 82.45% | Val Acc: 72.50%\n",
      "Epoch 06 | Train Acc: 84.44% | Val Acc: 72.96%\n",
      "Epoch 07 | Train Acc: 85.97% | Val Acc: 73.00%\n",
      "Epoch 08 | Train Acc: 87.59% | Val Acc: 73.82%\n",
      "Epoch 09 | Train Acc: 89.01% | Val Acc: 74.59%\n",
      "Epoch 10 | Train Acc: 90.15% | Val Acc: 74.17%\n",
      "Epoch 11 | Train Acc: 90.73% | Val Acc: 74.86%\n",
      "Epoch 12 | Train Acc: 91.81% | Val Acc: 74.20%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 74.20%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.60      0.64       861\n",
      "           benigno       0.90      0.89      0.90       855\n",
      "carcinoma squamoso       0.66      0.73      0.69       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 60.29% | Val Acc: 72.50%\n",
      "Epoch 02 | Train Acc: 71.49% | Val Acc: 72.50%\n",
      "Epoch 03 | Train Acc: 76.73% | Val Acc: 73.47%\n",
      "Epoch 04 | Train Acc: 79.51% | Val Acc: 72.54%\n",
      "Epoch 05 | Train Acc: 82.74% | Val Acc: 72.69%\n",
      "Epoch 06 | Train Acc: 84.57% | Val Acc: 74.09%\n",
      "Epoch 07 | Train Acc: 86.38% | Val Acc: 74.94%\n",
      "Epoch 08 | Train Acc: 87.86% | Val Acc: 73.89%\n",
      "Epoch 09 | Train Acc: 89.29% | Val Acc: 75.25%\n",
      "Epoch 10 | Train Acc: 90.38% | Val Acc: 75.14%\n",
      "Epoch 11 | Train Acc: 91.09% | Val Acc: 74.98%\n",
      "Epoch 12 | Train Acc: 92.18% | Val Acc: 74.44%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 74.44%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.56      0.62       862\n",
      "           benigno       0.88      0.92      0.90       854\n",
      "carcinoma squamoso       0.66      0.76      0.70       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 60.33% | Val Acc: 71.56%\n",
      "Epoch 02 | Train Acc: 70.58% | Val Acc: 73.15%\n",
      "Epoch 03 | Train Acc: 75.72% | Val Acc: 72.91%\n",
      "Epoch 04 | Train Acc: 79.20% | Val Acc: 74.58%\n",
      "Epoch 05 | Train Acc: 81.59% | Val Acc: 74.43%\n",
      "Epoch 06 | Train Acc: 84.55% | Val Acc: 74.27%\n",
      "Epoch 07 | Train Acc: 85.86% | Val Acc: 73.88%\n",
      "Epoch 08 | Train Acc: 87.57% | Val Acc: 75.05%\n",
      "Epoch 09 | Train Acc: 89.30% | Val Acc: 75.79%\n",
      "Epoch 10 | Train Acc: 89.70% | Val Acc: 75.90%\n",
      "Epoch 11 | Train Acc: 90.51% | Val Acc: 75.36%\n",
      "Epoch 12 | Train Acc: 91.75% | Val Acc: 76.72%\n",
      "Epoch 13 | Train Acc: 91.84% | Val Acc: 75.20%\n",
      "Epoch 14 | Train Acc: 92.66% | Val Acc: 75.94%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 75.94%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.70      0.59      0.64       862\n",
      "           benigno       0.93      0.89      0.91       854\n",
      "carcinoma squamoso       0.66      0.80      0.72       861\n",
      "\n",
      "          accuracy                           0.76      2577\n",
      "         macro avg       0.77      0.76      0.76      2577\n",
      "      weighted avg       0.77      0.76      0.76      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 60.68% | Val Acc: 72.60%\n",
      "Epoch 02 | Train Acc: 71.70% | Val Acc: 71.40%\n",
      "Epoch 03 | Train Acc: 77.33% | Val Acc: 72.02%\n",
      "Epoch 04 | Train Acc: 80.43% | Val Acc: 72.64%\n",
      "Epoch 05 | Train Acc: 82.19% | Val Acc: 72.64%\n",
      "Epoch 06 | Train Acc: 85.01% | Val Acc: 72.76%\n",
      "Epoch 07 | Train Acc: 87.09% | Val Acc: 73.19%\n",
      "Epoch 08 | Train Acc: 87.83% | Val Acc: 73.92%\n",
      "Epoch 09 | Train Acc: 89.36% | Val Acc: 73.46%\n",
      "Epoch 10 | Train Acc: 90.87% | Val Acc: 73.30%\n",
      "Epoch 11 | Train Acc: 91.59% | Val Acc: 72.95%\n",
      "Epoch 12 | Train Acc: 91.43% | Val Acc: 72.88%\n",
      "Epoch 13 | Train Acc: 92.36% | Val Acc: 74.70%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.70%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.68      0.58      0.63       862\n",
      "           benigno       0.90      0.93      0.91       854\n",
      "carcinoma squamoso       0.66      0.74      0.70       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.74      2577\n",
      "      weighted avg       0.75      0.75      0.74      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 8 - CV Mean Accuracy: 74.90% ¬± 0.62%\n",
      "\n",
      "[pca_data_2342_0.05] Config 9: {'hidden_dims': [512, 256, 128], 'batchnorm': True, 'dropout': 0.7, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [512, 256, 128], 'batchnorm': True, 'dropout': 0.7, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 57.89% | Val Acc: 71.72%\n",
      "Epoch 02 | Train Acc: 68.01% | Val Acc: 73.78%\n",
      "Epoch 03 | Train Acc: 72.13% | Val Acc: 73.58%\n",
      "Epoch 04 | Train Acc: 75.45% | Val Acc: 73.58%\n",
      "Epoch 05 | Train Acc: 77.95% | Val Acc: 73.62%\n",
      "Epoch 06 | Train Acc: 80.00% | Val Acc: 73.27%\n",
      "Epoch 07 | Train Acc: 80.60% | Val Acc: 74.52%\n",
      "Epoch 08 | Train Acc: 82.81% | Val Acc: 74.24%\n",
      "Epoch 09 | Train Acc: 84.05% | Val Acc: 75.10%\n",
      "Epoch 10 | Train Acc: 85.33% | Val Acc: 74.63%\n",
      "Epoch 11 | Train Acc: 86.66% | Val Acc: 76.07%\n",
      "Epoch 12 | Train Acc: 86.90% | Val Acc: 75.99%\n",
      "Epoch 13 | Train Acc: 87.97% | Val Acc: 75.45%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 75.45%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.62      0.65       861\n",
      "           benigno       0.93      0.89      0.91       855\n",
      "carcinoma squamoso       0.66      0.76      0.71       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.76      0.75      0.76      2578\n",
      "      weighted avg       0.76      0.75      0.76      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 57.97% | Val Acc: 68.35%\n",
      "Epoch 02 | Train Acc: 68.84% | Val Acc: 71.37%\n",
      "Epoch 03 | Train Acc: 72.63% | Val Acc: 72.23%\n",
      "Epoch 04 | Train Acc: 75.31% | Val Acc: 71.84%\n",
      "Epoch 05 | Train Acc: 77.95% | Val Acc: 72.23%\n",
      "Epoch 06 | Train Acc: 79.83% | Val Acc: 72.38%\n",
      "Epoch 07 | Train Acc: 81.19% | Val Acc: 72.27%\n",
      "Epoch 08 | Train Acc: 82.98% | Val Acc: 73.43%\n",
      "Epoch 09 | Train Acc: 84.32% | Val Acc: 72.77%\n",
      "Epoch 10 | Train Acc: 85.88% | Val Acc: 73.78%\n",
      "Epoch 11 | Train Acc: 86.02% | Val Acc: 73.43%\n",
      "Epoch 12 | Train Acc: 87.09% | Val Acc: 72.77%\n",
      "Epoch 13 | Train Acc: 87.90% | Val Acc: 73.58%\n",
      "Epoch 14 | Train Acc: 88.72% | Val Acc: 73.35%\n",
      "Epoch 15 | Train Acc: 89.31% | Val Acc: 73.08%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 73.08%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.56      0.61       861\n",
      "           benigno       0.92      0.88      0.90       855\n",
      "carcinoma squamoso       0.63      0.75      0.69       862\n",
      "\n",
      "          accuracy                           0.73      2578\n",
      "         macro avg       0.74      0.73      0.73      2578\n",
      "      weighted avg       0.74      0.73      0.73      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 57.68% | Val Acc: 70.75%\n",
      "Epoch 02 | Train Acc: 67.62% | Val Acc: 73.55%\n",
      "Epoch 03 | Train Acc: 72.32% | Val Acc: 73.27%\n",
      "Epoch 04 | Train Acc: 74.75% | Val Acc: 73.00%\n",
      "Epoch 05 | Train Acc: 77.04% | Val Acc: 73.86%\n",
      "Epoch 06 | Train Acc: 79.01% | Val Acc: 72.81%\n",
      "Epoch 07 | Train Acc: 81.18% | Val Acc: 73.58%\n",
      "Epoch 08 | Train Acc: 82.80% | Val Acc: 73.31%\n",
      "Epoch 09 | Train Acc: 83.27% | Val Acc: 74.09%\n",
      "Epoch 10 | Train Acc: 85.34% | Val Acc: 73.47%\n",
      "Epoch 11 | Train Acc: 85.90% | Val Acc: 74.71%\n",
      "Epoch 12 | Train Acc: 87.27% | Val Acc: 74.55%\n",
      "Epoch 13 | Train Acc: 87.94% | Val Acc: 75.33%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 75.33%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.62      0.65       862\n",
      "           benigno       0.91      0.91      0.91       854\n",
      "carcinoma squamoso       0.68      0.73      0.70       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.75      0.75      0.75      2578\n",
      "      weighted avg       0.75      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 56.41% | Val Acc: 67.44%\n",
      "Epoch 02 | Train Acc: 68.41% | Val Acc: 71.83%\n",
      "Epoch 03 | Train Acc: 72.36% | Val Acc: 72.53%\n",
      "Epoch 04 | Train Acc: 74.76% | Val Acc: 72.06%\n",
      "Epoch 05 | Train Acc: 76.74% | Val Acc: 71.67%\n",
      "Epoch 06 | Train Acc: 78.82% | Val Acc: 72.25%\n",
      "Epoch 07 | Train Acc: 80.93% | Val Acc: 72.95%\n",
      "Epoch 08 | Train Acc: 82.77% | Val Acc: 73.46%\n",
      "Epoch 09 | Train Acc: 82.92% | Val Acc: 73.54%\n",
      "Epoch 10 | Train Acc: 84.72% | Val Acc: 73.77%\n",
      "Epoch 11 | Train Acc: 86.00% | Val Acc: 74.23%\n",
      "Epoch 12 | Train Acc: 86.52% | Val Acc: 75.44%\n",
      "Epoch 13 | Train Acc: 87.18% | Val Acc: 75.16%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 75.16%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.68      0.62      0.65       862\n",
      "           benigno       0.91      0.92      0.91       854\n",
      "carcinoma squamoso       0.67      0.72      0.69       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 56.52% | Val Acc: 70.12%\n",
      "Epoch 02 | Train Acc: 68.54% | Val Acc: 71.25%\n",
      "Epoch 03 | Train Acc: 72.76% | Val Acc: 72.45%\n",
      "Epoch 04 | Train Acc: 75.61% | Val Acc: 71.63%\n",
      "Epoch 05 | Train Acc: 77.62% | Val Acc: 72.49%\n",
      "Epoch 06 | Train Acc: 79.50% | Val Acc: 73.07%\n",
      "Epoch 07 | Train Acc: 81.32% | Val Acc: 72.41%\n",
      "Epoch 08 | Train Acc: 83.24% | Val Acc: 72.18%\n",
      "Epoch 09 | Train Acc: 83.81% | Val Acc: 73.11%\n",
      "Epoch 10 | Train Acc: 85.27% | Val Acc: 74.00%\n",
      "Epoch 11 | Train Acc: 86.66% | Val Acc: 74.23%\n",
      "Epoch 12 | Train Acc: 86.71% | Val Acc: 74.66%\n",
      "Epoch 13 | Train Acc: 88.23% | Val Acc: 74.51%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.51%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.58      0.62       862\n",
      "           benigno       0.90      0.93      0.91       854\n",
      "carcinoma squamoso       0.66      0.73      0.69       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.74      0.75      0.74      2577\n",
      "      weighted avg       0.74      0.75      0.74      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 9 - CV Mean Accuracy: 74.71% ¬± 0.88%\n",
      "\n",
      "[pca_data_2342_0.05] Config 10: {'hidden_dims': [1024, 512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.7, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [1024, 512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.7, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 47.66% | Val Acc: 52.02%\n",
      "Epoch 02 | Train Acc: 61.06% | Val Acc: 61.75%\n",
      "Epoch 03 | Train Acc: 63.68% | Val Acc: 65.21%\n",
      "Epoch 04 | Train Acc: 64.92% | Val Acc: 68.39%\n",
      "Epoch 05 | Train Acc: 66.48% | Val Acc: 70.09%\n",
      "Epoch 06 | Train Acc: 68.80% | Val Acc: 70.67%\n",
      "Epoch 07 | Train Acc: 71.06% | Val Acc: 70.71%\n",
      "Epoch 08 | Train Acc: 73.47% | Val Acc: 72.54%\n",
      "Epoch 09 | Train Acc: 74.70% | Val Acc: 73.47%\n",
      "Epoch 10 | Train Acc: 75.99% | Val Acc: 73.24%\n",
      "Epoch 11 | Train Acc: 77.47% | Val Acc: 73.47%\n",
      "Epoch 12 | Train Acc: 79.52% | Val Acc: 73.55%\n",
      "Epoch 13 | Train Acc: 79.80% | Val Acc: 74.17%\n",
      "Epoch 14 | Train Acc: 79.83% | Val Acc: 74.28%\n",
      "Epoch 15 | Train Acc: 81.50% | Val Acc: 74.59%\n",
      "Epoch 16 | Train Acc: 81.91% | Val Acc: 74.98%\n",
      "Epoch 17 | Train Acc: 83.41% | Val Acc: 75.02%\n",
      "Epoch 18 | Train Acc: 83.71% | Val Acc: 74.28%\n",
      "Epoch 19 | Train Acc: 84.64% | Val Acc: 74.79%\n",
      "Epoch 20 | Train Acc: 85.29% | Val Acc: 75.72%\n",
      "Epoch 21 | Train Acc: 85.97% | Val Acc: 74.98%\n",
      "Epoch 22 | Train Acc: 86.69% | Val Acc: 76.07%\n",
      "Epoch 23 | Train Acc: 87.08% | Val Acc: 75.87%\n",
      "Epoch 24 | Train Acc: 87.87% | Val Acc: 76.30%\n",
      "Epoch 25 | Train Acc: 88.19% | Val Acc: 75.68%\n",
      "Epoch 26 | Train Acc: 88.87% | Val Acc: 77.23%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 77.23%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.70      0.64      0.67       861\n",
      "           benigno       0.94      0.90      0.92       855\n",
      "carcinoma squamoso       0.69      0.77      0.73       862\n",
      "\n",
      "          accuracy                           0.77      2578\n",
      "         macro avg       0.78      0.77      0.77      2578\n",
      "      weighted avg       0.78      0.77      0.77      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 48.29% | Val Acc: 54.15%\n",
      "Epoch 02 | Train Acc: 61.22% | Val Acc: 61.68%\n",
      "Epoch 03 | Train Acc: 63.80% | Val Acc: 65.09%\n",
      "Epoch 04 | Train Acc: 65.34% | Val Acc: 66.99%\n",
      "Epoch 05 | Train Acc: 67.66% | Val Acc: 67.84%\n",
      "Epoch 06 | Train Acc: 69.34% | Val Acc: 67.53%\n",
      "Epoch 07 | Train Acc: 71.73% | Val Acc: 70.02%\n",
      "Epoch 08 | Train Acc: 73.19% | Val Acc: 71.37%\n",
      "Epoch 09 | Train Acc: 75.41% | Val Acc: 71.61%\n",
      "Epoch 10 | Train Acc: 77.30% | Val Acc: 71.33%\n",
      "Epoch 11 | Train Acc: 78.62% | Val Acc: 72.38%\n",
      "Epoch 12 | Train Acc: 79.83% | Val Acc: 70.95%\n",
      "Epoch 13 | Train Acc: 80.58% | Val Acc: 73.12%\n",
      "Epoch 14 | Train Acc: 81.91% | Val Acc: 72.54%\n",
      "Epoch 15 | Train Acc: 82.61% | Val Acc: 73.12%\n",
      "Epoch 16 | Train Acc: 82.84% | Val Acc: 73.55%\n",
      "Epoch 17 | Train Acc: 84.00% | Val Acc: 74.83%\n",
      "Epoch 18 | Train Acc: 84.57% | Val Acc: 72.77%\n",
      "Epoch 19 | Train Acc: 84.89% | Val Acc: 73.66%\n",
      "Epoch 20 | Train Acc: 86.01% | Val Acc: 73.86%\n",
      "Epoch 21 | Train Acc: 86.86% | Val Acc: 73.51%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 73.51%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.64      0.62      0.63       861\n",
      "           benigno       0.90      0.91      0.90       855\n",
      "carcinoma squamoso       0.67      0.68      0.67       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.73      0.74      0.74      2578\n",
      "      weighted avg       0.73      0.74      0.73      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 42.38% | Val Acc: 53.26%\n",
      "Epoch 02 | Train Acc: 60.02% | Val Acc: 65.21%\n",
      "Epoch 03 | Train Acc: 64.16% | Val Acc: 67.92%\n",
      "Epoch 04 | Train Acc: 65.27% | Val Acc: 70.25%\n",
      "Epoch 05 | Train Acc: 68.02% | Val Acc: 69.55%\n",
      "Epoch 06 | Train Acc: 69.80% | Val Acc: 70.36%\n",
      "Epoch 07 | Train Acc: 71.14% | Val Acc: 70.83%\n",
      "Epoch 08 | Train Acc: 73.42% | Val Acc: 72.96%\n",
      "Epoch 09 | Train Acc: 74.85% | Val Acc: 71.92%\n",
      "Epoch 10 | Train Acc: 76.53% | Val Acc: 72.96%\n",
      "Epoch 11 | Train Acc: 78.44% | Val Acc: 72.38%\n",
      "Epoch 12 | Train Acc: 79.81% | Val Acc: 72.15%\n",
      "Epoch 13 | Train Acc: 80.63% | Val Acc: 72.50%\n",
      "Epoch 14 | Train Acc: 81.35% | Val Acc: 73.35%\n",
      "Epoch 15 | Train Acc: 82.43% | Val Acc: 74.13%\n",
      "Epoch 16 | Train Acc: 83.73% | Val Acc: 73.47%\n",
      "Epoch 17 | Train Acc: 84.29% | Val Acc: 73.93%\n",
      "Epoch 18 | Train Acc: 85.28% | Val Acc: 74.17%\n",
      "Epoch 19 | Train Acc: 86.03% | Val Acc: 74.63%\n",
      "Epoch 20 | Train Acc: 86.62% | Val Acc: 74.32%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 74.32%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.62      0.66      0.64       862\n",
      "           benigno       0.96      0.87      0.91       854\n",
      "carcinoma squamoso       0.68      0.69      0.69       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.75      0.74      0.75      2578\n",
      "      weighted avg       0.75      0.74      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 46.08% | Val Acc: 55.34%\n",
      "Epoch 02 | Train Acc: 60.62% | Val Acc: 55.49%\n",
      "Epoch 03 | Train Acc: 63.40% | Val Acc: 62.48%\n",
      "Epoch 04 | Train Acc: 64.43% | Val Acc: 64.65%\n",
      "Epoch 05 | Train Acc: 66.47% | Val Acc: 65.77%\n",
      "Epoch 06 | Train Acc: 67.40% | Val Acc: 70.59%\n",
      "Epoch 07 | Train Acc: 69.29% | Val Acc: 69.38%\n",
      "Epoch 08 | Train Acc: 71.35% | Val Acc: 70.97%\n",
      "Epoch 09 | Train Acc: 73.30% | Val Acc: 70.74%\n",
      "Epoch 10 | Train Acc: 74.21% | Val Acc: 71.71%\n",
      "Epoch 11 | Train Acc: 76.76% | Val Acc: 73.85%\n",
      "Epoch 12 | Train Acc: 77.90% | Val Acc: 71.56%\n",
      "Epoch 13 | Train Acc: 79.15% | Val Acc: 73.26%\n",
      "Epoch 14 | Train Acc: 80.11% | Val Acc: 72.95%\n",
      "Epoch 15 | Train Acc: 81.58% | Val Acc: 73.92%\n",
      "Epoch 16 | Train Acc: 82.12% | Val Acc: 74.27%\n",
      "Epoch 17 | Train Acc: 83.30% | Val Acc: 74.82%\n",
      "Epoch 18 | Train Acc: 83.99% | Val Acc: 75.75%\n",
      "Epoch 19 | Train Acc: 86.03% | Val Acc: 75.67%\n",
      "Epoch 20 | Train Acc: 86.00% | Val Acc: 76.10%\n",
      "Epoch 21 | Train Acc: 85.76% | Val Acc: 76.17%\n",
      "Epoch 22 | Train Acc: 86.47% | Val Acc: 75.13%\n",
      "Epoch 23 | Train Acc: 88.15% | Val Acc: 76.06%\n",
      "Epoch 24 | Train Acc: 87.50% | Val Acc: 75.28%\n",
      "Epoch 25 | Train Acc: 88.48% | Val Acc: 76.56%\n",
      "Epoch 26 | Train Acc: 88.89% | Val Acc: 76.02%\n",
      "Epoch 27 | Train Acc: 89.96% | Val Acc: 76.83%\n",
      "Epoch 28 | Train Acc: 89.56% | Val Acc: 77.14%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 77.14%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.72      0.63      0.67       862\n",
      "           benigno       0.92      0.91      0.92       854\n",
      "carcinoma squamoso       0.68      0.78      0.73       861\n",
      "\n",
      "          accuracy                           0.77      2577\n",
      "         macro avg       0.77      0.77      0.77      2577\n",
      "      weighted avg       0.77      0.77      0.77      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 47.85% | Val Acc: 55.57%\n",
      "Epoch 02 | Train Acc: 60.60% | Val Acc: 57.04%\n",
      "Epoch 03 | Train Acc: 62.18% | Val Acc: 62.09%\n",
      "Epoch 04 | Train Acc: 64.03% | Val Acc: 62.94%\n",
      "Epoch 05 | Train Acc: 65.13% | Val Acc: 64.42%\n",
      "Epoch 06 | Train Acc: 66.40% | Val Acc: 67.56%\n",
      "Epoch 07 | Train Acc: 67.32% | Val Acc: 67.21%\n",
      "Epoch 08 | Train Acc: 69.27% | Val Acc: 71.01%\n",
      "Epoch 09 | Train Acc: 71.61% | Val Acc: 71.13%\n",
      "Epoch 10 | Train Acc: 73.25% | Val Acc: 71.09%\n",
      "Epoch 11 | Train Acc: 74.62% | Val Acc: 70.35%\n",
      "Epoch 12 | Train Acc: 76.10% | Val Acc: 73.96%\n",
      "Epoch 13 | Train Acc: 78.47% | Val Acc: 71.79%\n",
      "Epoch 14 | Train Acc: 79.37% | Val Acc: 73.61%\n",
      "Epoch 15 | Train Acc: 80.47% | Val Acc: 72.64%\n",
      "Epoch 16 | Train Acc: 81.93% | Val Acc: 72.76%\n",
      "Epoch 17 | Train Acc: 82.20% | Val Acc: 72.84%\n",
      "Epoch 18 | Train Acc: 82.92% | Val Acc: 73.69%\n",
      "Epoch 19 | Train Acc: 84.20% | Val Acc: 72.72%\n",
      "Epoch 20 | Train Acc: 84.79% | Val Acc: 73.96%\n",
      "Epoch 21 | Train Acc: 85.94% | Val Acc: 75.75%\n",
      "Epoch 22 | Train Acc: 86.15% | Val Acc: 73.54%\n",
      "Epoch 23 | Train Acc: 87.70% | Val Acc: 74.66%\n",
      "Epoch 24 | Train Acc: 87.73% | Val Acc: 74.89%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.89%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.60      0.63       862\n",
      "           benigno       0.92      0.90      0.91       854\n",
      "carcinoma squamoso       0.66      0.74      0.70       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 10 - CV Mean Accuracy: 75.42% ¬± 1.51%\n",
      "\n",
      "[pca_data_2342_0.05] Config 11: {'hidden_dims': [1024, 512, 256, 128, 64, 32], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [1024, 512, 256, 128, 64, 32], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 51.11% | Val Acc: 67.69%\n",
      "Epoch 02 | Train Acc: 64.10% | Val Acc: 67.61%\n",
      "Epoch 03 | Train Acc: 70.10% | Val Acc: 74.09%\n",
      "Epoch 04 | Train Acc: 73.86% | Val Acc: 74.01%\n",
      "Epoch 05 | Train Acc: 77.26% | Val Acc: 72.89%\n",
      "Epoch 06 | Train Acc: 79.95% | Val Acc: 72.19%\n",
      "Epoch 07 | Train Acc: 82.03% | Val Acc: 73.66%\n",
      "Epoch 08 | Train Acc: 83.85% | Val Acc: 75.29%\n",
      "Epoch 09 | Train Acc: 86.00% | Val Acc: 73.62%\n",
      "Epoch 10 | Train Acc: 86.66% | Val Acc: 74.20%\n",
      "Epoch 11 | Train Acc: 87.37% | Val Acc: 75.52%\n",
      "Epoch 12 | Train Acc: 89.09% | Val Acc: 73.35%\n",
      "Epoch 13 | Train Acc: 87.97% | Val Acc: 74.55%\n",
      "Epoch 14 | Train Acc: 90.88% | Val Acc: 74.63%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 74.63%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.62      0.64       861\n",
      "           benigno       0.89      0.92      0.90       855\n",
      "carcinoma squamoso       0.67      0.70      0.69       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.74      0.75      0.74      2578\n",
      "      weighted avg       0.74      0.75      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 51.84% | Val Acc: 63.46%\n",
      "Epoch 02 | Train Acc: 65.38% | Val Acc: 67.26%\n",
      "Epoch 03 | Train Acc: 70.28% | Val Acc: 70.44%\n",
      "Epoch 04 | Train Acc: 74.19% | Val Acc: 71.53%\n",
      "Epoch 05 | Train Acc: 77.62% | Val Acc: 71.18%\n",
      "Epoch 06 | Train Acc: 79.15% | Val Acc: 72.38%\n",
      "Epoch 07 | Train Acc: 81.55% | Val Acc: 72.34%\n",
      "Epoch 08 | Train Acc: 83.72% | Val Acc: 72.96%\n",
      "Epoch 09 | Train Acc: 85.58% | Val Acc: 73.39%\n",
      "Epoch 10 | Train Acc: 86.51% | Val Acc: 72.34%\n",
      "Epoch 11 | Train Acc: 87.42% | Val Acc: 73.27%\n",
      "Epoch 12 | Train Acc: 88.32% | Val Acc: 73.43%\n",
      "Epoch 13 | Train Acc: 90.35% | Val Acc: 73.70%\n",
      "Epoch 14 | Train Acc: 90.66% | Val Acc: 74.13%\n",
      "Epoch 15 | Train Acc: 91.77% | Val Acc: 73.62%\n",
      "Epoch 16 | Train Acc: 91.66% | Val Acc: 74.44%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 74.44%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.65      0.66      0.66       861\n",
      "           benigno       0.92      0.88      0.90       855\n",
      "carcinoma squamoso       0.67      0.70      0.68       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.75      0.74      0.75      2578\n",
      "      weighted avg       0.75      0.74      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 52.23% | Val Acc: 64.47%\n",
      "Epoch 02 | Train Acc: 64.39% | Val Acc: 68.58%\n",
      "Epoch 03 | Train Acc: 69.19% | Val Acc: 71.06%\n",
      "Epoch 04 | Train Acc: 73.47% | Val Acc: 72.61%\n",
      "Epoch 05 | Train Acc: 76.70% | Val Acc: 72.27%\n",
      "Epoch 06 | Train Acc: 79.99% | Val Acc: 73.39%\n",
      "Epoch 07 | Train Acc: 82.00% | Val Acc: 72.58%\n",
      "Epoch 08 | Train Acc: 83.39% | Val Acc: 73.04%\n",
      "Epoch 09 | Train Acc: 84.82% | Val Acc: 72.73%\n",
      "Epoch 10 | Train Acc: 86.22% | Val Acc: 73.39%\n",
      "Epoch 11 | Train Acc: 87.92% | Val Acc: 73.97%\n",
      "Epoch 12 | Train Acc: 89.63% | Val Acc: 72.69%\n",
      "Epoch 13 | Train Acc: 89.79% | Val Acc: 73.55%\n",
      "Epoch 14 | Train Acc: 90.77% | Val Acc: 74.86%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 74.86%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.63      0.70      0.66       862\n",
      "           benigno       0.94      0.89      0.91       854\n",
      "carcinoma squamoso       0.70      0.67      0.68       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.76      0.75      0.75      2578\n",
      "      weighted avg       0.76      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 50.92% | Val Acc: 62.44%\n",
      "Epoch 02 | Train Acc: 63.59% | Val Acc: 68.10%\n",
      "Epoch 03 | Train Acc: 69.26% | Val Acc: 72.76%\n",
      "Epoch 04 | Train Acc: 72.08% | Val Acc: 72.49%\n",
      "Epoch 05 | Train Acc: 75.38% | Val Acc: 72.18%\n",
      "Epoch 06 | Train Acc: 78.22% | Val Acc: 73.03%\n",
      "Epoch 07 | Train Acc: 80.74% | Val Acc: 72.91%\n",
      "Epoch 08 | Train Acc: 82.52% | Val Acc: 74.93%\n",
      "Epoch 09 | Train Acc: 84.50% | Val Acc: 74.66%\n",
      "Epoch 10 | Train Acc: 85.67% | Val Acc: 74.97%\n",
      "Epoch 11 | Train Acc: 87.37% | Val Acc: 75.55%\n",
      "Epoch 12 | Train Acc: 88.21% | Val Acc: 74.27%\n",
      "Epoch 13 | Train Acc: 89.59% | Val Acc: 75.24%\n",
      "Epoch 14 | Train Acc: 90.51% | Val Acc: 76.17%\n",
      "Epoch 15 | Train Acc: 91.18% | Val Acc: 74.12%\n",
      "Epoch 16 | Train Acc: 91.86% | Val Acc: 76.83%\n",
      "Epoch 17 | Train Acc: 92.23% | Val Acc: 75.13%\n",
      "Epoch 18 | Train Acc: 92.83% | Val Acc: 76.79%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 76.79%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.68      0.67      0.67       862\n",
      "           benigno       0.93      0.90      0.92       854\n",
      "carcinoma squamoso       0.70      0.73      0.72       861\n",
      "\n",
      "          accuracy                           0.77      2577\n",
      "         macro avg       0.77      0.77      0.77      2577\n",
      "      weighted avg       0.77      0.77      0.77      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 52.16% | Val Acc: 69.07%\n",
      "Epoch 02 | Train Acc: 66.30% | Val Acc: 70.78%\n",
      "Epoch 03 | Train Acc: 72.59% | Val Acc: 72.56%\n",
      "Epoch 04 | Train Acc: 76.40% | Val Acc: 72.22%\n",
      "Epoch 05 | Train Acc: 79.17% | Val Acc: 72.68%\n",
      "Epoch 06 | Train Acc: 81.61% | Val Acc: 73.30%\n",
      "Epoch 07 | Train Acc: 83.66% | Val Acc: 72.88%\n",
      "Epoch 08 | Train Acc: 85.13% | Val Acc: 72.37%\n",
      "Epoch 09 | Train Acc: 86.55% | Val Acc: 74.93%\n",
      "Epoch 10 | Train Acc: 87.99% | Val Acc: 73.85%\n",
      "Epoch 11 | Train Acc: 88.24% | Val Acc: 72.45%\n",
      "Epoch 12 | Train Acc: 90.11% | Val Acc: 72.84%\n",
      "Epoch 13 | Train Acc: 90.65% | Val Acc: 73.85%\n",
      "Epoch 14 | Train Acc: 90.98% | Val Acc: 73.69%\n",
      "Epoch 15 | Train Acc: 91.80% | Val Acc: 74.12%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.12%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.64      0.65      0.64       862\n",
      "           benigno       0.95      0.87      0.91       854\n",
      "carcinoma squamoso       0.66      0.71      0.69       861\n",
      "\n",
      "          accuracy                           0.74      2577\n",
      "         macro avg       0.75      0.74      0.74      2577\n",
      "      weighted avg       0.75      0.74      0.74      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 11 - CV Mean Accuracy: 74.97% ¬± 0.95%\n",
      "\n",
      "[pca_data_2342_0.05] Config 12: {'hidden_dims': [1024, 512, 256, 128, 64, 32], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [1024, 512, 256, 128, 64, 32], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 46.71% | Val Acc: 58.07%\n",
      "Epoch 02 | Train Acc: 59.99% | Val Acc: 63.03%\n",
      "Epoch 03 | Train Acc: 62.12% | Val Acc: 60.40%\n",
      "Epoch 04 | Train Acc: 63.59% | Val Acc: 63.46%\n",
      "Epoch 05 | Train Acc: 66.05% | Val Acc: 66.29%\n",
      "Epoch 06 | Train Acc: 67.27% | Val Acc: 64.66%\n",
      "Epoch 07 | Train Acc: 68.29% | Val Acc: 69.51%\n",
      "Epoch 08 | Train Acc: 69.94% | Val Acc: 71.96%\n",
      "Epoch 09 | Train Acc: 71.49% | Val Acc: 70.91%\n",
      "Epoch 10 | Train Acc: 73.63% | Val Acc: 72.89%\n",
      "Epoch 11 | Train Acc: 75.95% | Val Acc: 73.39%\n",
      "Epoch 12 | Train Acc: 77.03% | Val Acc: 71.96%\n",
      "Epoch 13 | Train Acc: 79.79% | Val Acc: 72.89%\n",
      "Epoch 14 | Train Acc: 80.63% | Val Acc: 73.04%\n",
      "Epoch 15 | Train Acc: 81.12% | Val Acc: 73.89%\n",
      "Epoch 16 | Train Acc: 82.90% | Val Acc: 74.32%\n",
      "Epoch 17 | Train Acc: 83.10% | Val Acc: 73.62%\n",
      "Epoch 18 | Train Acc: 84.59% | Val Acc: 73.86%\n",
      "Epoch 19 | Train Acc: 85.74% | Val Acc: 73.70%\n",
      "Epoch 20 | Train Acc: 86.56% | Val Acc: 75.80%\n",
      "Epoch 21 | Train Acc: 86.81% | Val Acc: 75.68%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 75.68%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.65      0.68      0.67       861\n",
      "           benigno       0.90      0.92      0.91       855\n",
      "carcinoma squamoso       0.71      0.67      0.69       862\n",
      "\n",
      "          accuracy                           0.76      2578\n",
      "         macro avg       0.76      0.76      0.76      2578\n",
      "      weighted avg       0.76      0.76      0.76      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 44.99% | Val Acc: 55.04%\n",
      "Epoch 02 | Train Acc: 59.54% | Val Acc: 58.92%\n",
      "Epoch 03 | Train Acc: 62.13% | Val Acc: 61.79%\n",
      "Epoch 04 | Train Acc: 63.10% | Val Acc: 64.62%\n",
      "Epoch 05 | Train Acc: 64.87% | Val Acc: 65.98%\n",
      "Epoch 06 | Train Acc: 67.35% | Val Acc: 67.49%\n",
      "Epoch 07 | Train Acc: 69.19% | Val Acc: 68.35%\n",
      "Epoch 08 | Train Acc: 70.63% | Val Acc: 70.67%\n",
      "Epoch 09 | Train Acc: 72.71% | Val Acc: 71.22%\n",
      "Epoch 10 | Train Acc: 73.78% | Val Acc: 71.37%\n",
      "Epoch 11 | Train Acc: 76.15% | Val Acc: 70.99%\n",
      "Epoch 12 | Train Acc: 77.31% | Val Acc: 72.15%\n",
      "Epoch 13 | Train Acc: 79.41% | Val Acc: 72.07%\n",
      "Epoch 14 | Train Acc: 81.25% | Val Acc: 69.90%\n",
      "Epoch 15 | Train Acc: 82.64% | Val Acc: 73.00%\n",
      "Epoch 16 | Train Acc: 83.55% | Val Acc: 71.76%\n",
      "Epoch 17 | Train Acc: 83.72% | Val Acc: 73.97%\n",
      "Epoch 18 | Train Acc: 85.27% | Val Acc: 73.39%\n",
      "Epoch 19 | Train Acc: 85.53% | Val Acc: 74.79%\n",
      "Epoch 20 | Train Acc: 86.98% | Val Acc: 74.17%\n",
      "Epoch 21 | Train Acc: 86.69% | Val Acc: 74.44%\n",
      "Epoch 22 | Train Acc: 87.45% | Val Acc: 73.39%\n",
      "Epoch 23 | Train Acc: 88.84% | Val Acc: 75.14%\n",
      "Epoch 24 | Train Acc: 88.44% | Val Acc: 74.40%\n",
      "Epoch 25 | Train Acc: 89.41% | Val Acc: 74.83%\n",
      "Epoch 26 | Train Acc: 89.70% | Val Acc: 75.10%\n",
      "Epoch 27 | Train Acc: 90.33% | Val Acc: 75.29%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 75.29%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.62      0.64       861\n",
      "           benigno       0.93      0.90      0.91       855\n",
      "carcinoma squamoso       0.68      0.74      0.71       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.76      0.75      0.75      2578\n",
      "      weighted avg       0.76      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 47.90% | Val Acc: 52.79%\n",
      "Epoch 02 | Train Acc: 59.54% | Val Acc: 58.92%\n",
      "Epoch 03 | Train Acc: 62.29% | Val Acc: 63.38%\n",
      "Epoch 04 | Train Acc: 63.57% | Val Acc: 63.30%\n",
      "Epoch 05 | Train Acc: 64.78% | Val Acc: 66.72%\n",
      "Epoch 06 | Train Acc: 66.08% | Val Acc: 65.98%\n",
      "Epoch 07 | Train Acc: 67.34% | Val Acc: 64.62%\n",
      "Epoch 08 | Train Acc: 67.73% | Val Acc: 70.60%\n",
      "Epoch 09 | Train Acc: 69.15% | Val Acc: 72.65%\n",
      "Epoch 10 | Train Acc: 71.11% | Val Acc: 70.60%\n",
      "Epoch 11 | Train Acc: 73.28% | Val Acc: 72.77%\n",
      "Epoch 12 | Train Acc: 75.17% | Val Acc: 72.96%\n",
      "Epoch 13 | Train Acc: 76.88% | Val Acc: 71.92%\n",
      "Epoch 14 | Train Acc: 78.38% | Val Acc: 72.96%\n",
      "Epoch 15 | Train Acc: 79.30% | Val Acc: 74.01%\n",
      "Epoch 16 | Train Acc: 80.42% | Val Acc: 74.05%\n",
      "Epoch 17 | Train Acc: 81.58% | Val Acc: 72.11%\n",
      "Epoch 18 | Train Acc: 83.18% | Val Acc: 73.89%\n",
      "Epoch 19 | Train Acc: 84.25% | Val Acc: 73.93%\n",
      "Epoch 20 | Train Acc: 84.31% | Val Acc: 73.93%\n",
      "Epoch 21 | Train Acc: 85.86% | Val Acc: 74.59%\n",
      "Epoch 22 | Train Acc: 86.45% | Val Acc: 74.71%\n",
      "Epoch 23 | Train Acc: 87.06% | Val Acc: 75.41%\n",
      "Epoch 24 | Train Acc: 88.04% | Val Acc: 74.98%\n",
      "Epoch 25 | Train Acc: 87.77% | Val Acc: 73.43%\n",
      "Epoch 26 | Train Acc: 87.63% | Val Acc: 75.64%\n",
      "Epoch 27 | Train Acc: 88.41% | Val Acc: 75.91%\n",
      "Epoch 28 | Train Acc: 88.68% | Val Acc: 74.13%\n",
      "Epoch 29 | Train Acc: 89.19% | Val Acc: 75.80%\n",
      "Epoch 30 | Train Acc: 89.23% | Val Acc: 76.69%\n",
      "Epoch 31 | Train Acc: 89.80% | Val Acc: 76.07%\n",
      "Epoch 32 | Train Acc: 90.95% | Val Acc: 76.14%\n",
      "Epoch 33 | Train Acc: 90.97% | Val Acc: 76.88%\n",
      "Epoch 34 | Train Acc: 91.55% | Val Acc: 76.14%\n",
      "Epoch 35 | Train Acc: 91.64% | Val Acc: 76.96%\n",
      "Epoch 36 | Train Acc: 91.60% | Val Acc: 76.73%\n",
      "Epoch 37 | Train Acc: 92.29% | Val Acc: 76.49%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 76.49%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.66      0.68      0.67       862\n",
      "           benigno       0.94      0.89      0.92       854\n",
      "carcinoma squamoso       0.71      0.73      0.72       862\n",
      "\n",
      "          accuracy                           0.76      2578\n",
      "         macro avg       0.77      0.77      0.77      2578\n",
      "      weighted avg       0.77      0.76      0.77      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 43.82% | Val Acc: 53.40%\n",
      "Epoch 02 | Train Acc: 59.43% | Val Acc: 60.11%\n",
      "Epoch 03 | Train Acc: 62.74% | Val Acc: 65.93%\n",
      "Epoch 04 | Train Acc: 63.69% | Val Acc: 63.68%\n",
      "Epoch 05 | Train Acc: 65.98% | Val Acc: 66.28%\n",
      "Epoch 06 | Train Acc: 66.73% | Val Acc: 68.72%\n",
      "Epoch 07 | Train Acc: 68.04% | Val Acc: 70.90%\n",
      "Epoch 08 | Train Acc: 70.58% | Val Acc: 70.16%\n",
      "Epoch 09 | Train Acc: 72.76% | Val Acc: 71.63%\n",
      "Epoch 10 | Train Acc: 74.76% | Val Acc: 72.33%\n",
      "Epoch 11 | Train Acc: 76.99% | Val Acc: 73.34%\n",
      "Epoch 12 | Train Acc: 78.25% | Val Acc: 73.73%\n",
      "Epoch 13 | Train Acc: 80.16% | Val Acc: 74.39%\n",
      "Epoch 14 | Train Acc: 80.99% | Val Acc: 73.96%\n",
      "Epoch 15 | Train Acc: 82.44% | Val Acc: 74.08%\n",
      "Epoch 16 | Train Acc: 84.30% | Val Acc: 75.32%\n",
      "Epoch 17 | Train Acc: 84.26% | Val Acc: 75.28%\n",
      "Epoch 18 | Train Acc: 85.25% | Val Acc: 75.94%\n",
      "Epoch 19 | Train Acc: 86.30% | Val Acc: 75.55%\n",
      "Epoch 20 | Train Acc: 86.59% | Val Acc: 75.40%\n",
      "Epoch 21 | Train Acc: 87.42% | Val Acc: 74.89%\n",
      "Epoch 22 | Train Acc: 87.49% | Val Acc: 74.08%\n",
      "Epoch 23 | Train Acc: 88.30% | Val Acc: 75.98%\n",
      "Epoch 24 | Train Acc: 88.87% | Val Acc: 76.48%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 76.48%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.64      0.66       862\n",
      "           benigno       0.90      0.93      0.92       854\n",
      "carcinoma squamoso       0.69      0.73      0.71       861\n",
      "\n",
      "          accuracy                           0.76      2577\n",
      "         macro avg       0.76      0.77      0.76      2577\n",
      "      weighted avg       0.76      0.76      0.76      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 44.50% | Val Acc: 53.86%\n",
      "Epoch 02 | Train Acc: 59.28% | Val Acc: 61.31%\n",
      "Epoch 03 | Train Acc: 62.90% | Val Acc: 62.59%\n",
      "Epoch 04 | Train Acc: 63.83% | Val Acc: 63.68%\n",
      "Epoch 05 | Train Acc: 65.43% | Val Acc: 66.16%\n",
      "Epoch 06 | Train Acc: 67.30% | Val Acc: 67.75%\n",
      "Epoch 07 | Train Acc: 70.08% | Val Acc: 71.79%\n",
      "Epoch 08 | Train Acc: 71.17% | Val Acc: 71.91%\n",
      "Epoch 09 | Train Acc: 73.97% | Val Acc: 72.22%\n",
      "Epoch 10 | Train Acc: 75.27% | Val Acc: 72.68%\n",
      "Epoch 11 | Train Acc: 77.10% | Val Acc: 72.64%\n",
      "Epoch 12 | Train Acc: 78.75% | Val Acc: 72.53%\n",
      "Epoch 13 | Train Acc: 79.71% | Val Acc: 72.84%\n",
      "Epoch 14 | Train Acc: 80.81% | Val Acc: 73.61%\n",
      "Epoch 15 | Train Acc: 82.02% | Val Acc: 74.27%\n",
      "Epoch 16 | Train Acc: 83.08% | Val Acc: 75.55%\n",
      "Epoch 17 | Train Acc: 83.80% | Val Acc: 75.09%\n",
      "Epoch 18 | Train Acc: 85.05% | Val Acc: 74.35%\n",
      "Epoch 19 | Train Acc: 85.95% | Val Acc: 75.32%\n",
      "Epoch 20 | Train Acc: 86.98% | Val Acc: 75.32%\n",
      "Epoch 21 | Train Acc: 87.37% | Val Acc: 75.82%\n",
      "Epoch 22 | Train Acc: 87.73% | Val Acc: 74.08%\n",
      "Epoch 23 | Train Acc: 88.15% | Val Acc: 76.29%\n",
      "Epoch 24 | Train Acc: 88.35% | Val Acc: 74.78%\n",
      "Epoch 25 | Train Acc: 88.73% | Val Acc: 75.51%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 75.51%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.58      0.63       862\n",
      "           benigno       0.89      0.95      0.92       854\n",
      "carcinoma squamoso       0.67      0.74      0.70       861\n",
      "\n",
      "          accuracy                           0.76      2577\n",
      "         macro avg       0.75      0.76      0.75      2577\n",
      "      weighted avg       0.75      0.76      0.75      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 12 - CV Mean Accuracy: 75.89% ¬± 0.50%\n",
      "\n",
      "[pca_data_2342_0.05] Config 13: {'hidden_dims': [1024, 512, 256, 128, 64, 32, 16], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [1024, 512, 256, 128, 64, 32, 16], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 37.74% | Val Acc: 44.76%\n",
      "Epoch 02 | Train Acc: 51.88% | Val Acc: 50.81%\n",
      "Epoch 03 | Train Acc: 57.16% | Val Acc: 54.03%\n",
      "Epoch 04 | Train Acc: 59.62% | Val Acc: 55.24%\n",
      "Epoch 05 | Train Acc: 61.22% | Val Acc: 62.10%\n",
      "Epoch 06 | Train Acc: 62.03% | Val Acc: 61.37%\n",
      "Epoch 07 | Train Acc: 62.63% | Val Acc: 62.76%\n",
      "Epoch 08 | Train Acc: 62.21% | Val Acc: 63.69%\n",
      "Epoch 09 | Train Acc: 62.98% | Val Acc: 62.53%\n",
      "Epoch 10 | Train Acc: 63.71% | Val Acc: 66.49%\n",
      "Epoch 11 | Train Acc: 63.51% | Val Acc: 62.80%\n",
      "Epoch 12 | Train Acc: 63.87% | Val Acc: 65.63%\n",
      "Epoch 13 | Train Acc: 64.85% | Val Acc: 65.32%\n",
      "Epoch 14 | Train Acc: 64.53% | Val Acc: 65.44%\n",
      "Epoch 15 | Train Acc: 64.68% | Val Acc: 65.63%\n",
      "Epoch 16 | Train Acc: 65.07% | Val Acc: 67.53%\n",
      "Epoch 17 | Train Acc: 66.05% | Val Acc: 66.80%\n",
      "Epoch 18 | Train Acc: 66.29% | Val Acc: 68.00%\n",
      "Epoch 19 | Train Acc: 65.54% | Val Acc: 69.32%\n",
      "Epoch 20 | Train Acc: 67.35% | Val Acc: 70.36%\n",
      "Epoch 21 | Train Acc: 66.15% | Val Acc: 65.48%\n",
      "Epoch 22 | Train Acc: 67.01% | Val Acc: 70.60%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 70.60%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.57      0.66      0.61       861\n",
      "           benigno       0.91      0.91      0.91       855\n",
      "carcinoma squamoso       0.65      0.55      0.59       862\n",
      "\n",
      "          accuracy                           0.71      2578\n",
      "         macro avg       0.71      0.71      0.71      2578\n",
      "      weighted avg       0.71      0.71      0.71      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 35.06% | Val Acc: 45.81%\n",
      "Epoch 02 | Train Acc: 46.96% | Val Acc: 53.14%\n",
      "Epoch 03 | Train Acc: 57.89% | Val Acc: 61.44%\n",
      "Epoch 04 | Train Acc: 60.77% | Val Acc: 61.60%\n",
      "Epoch 05 | Train Acc: 62.43% | Val Acc: 62.49%\n",
      "Epoch 06 | Train Acc: 62.71% | Val Acc: 62.84%\n",
      "Epoch 07 | Train Acc: 64.97% | Val Acc: 64.47%\n",
      "Epoch 08 | Train Acc: 64.29% | Val Acc: 62.18%\n",
      "Epoch 09 | Train Acc: 64.69% | Val Acc: 63.54%\n",
      "Epoch 10 | Train Acc: 65.81% | Val Acc: 68.19%\n",
      "Epoch 11 | Train Acc: 66.38% | Val Acc: 67.46%\n",
      "Epoch 12 | Train Acc: 67.19% | Val Acc: 67.46%\n",
      "Epoch 13 | Train Acc: 68.79% | Val Acc: 69.71%\n",
      "Epoch 14 | Train Acc: 69.57% | Val Acc: 70.67%\n",
      "Epoch 15 | Train Acc: 70.28% | Val Acc: 71.76%\n",
      "Epoch 16 | Train Acc: 71.77% | Val Acc: 72.23%\n",
      "Epoch 17 | Train Acc: 72.28% | Val Acc: 70.95%\n",
      "Epoch 18 | Train Acc: 73.14% | Val Acc: 69.74%\n",
      "Epoch 19 | Train Acc: 73.45% | Val Acc: 72.11%\n",
      "Epoch 20 | Train Acc: 74.66% | Val Acc: 72.58%\n",
      "Epoch 21 | Train Acc: 75.64% | Val Acc: 70.33%\n",
      "Epoch 22 | Train Acc: 76.67% | Val Acc: 72.34%\n",
      "Epoch 23 | Train Acc: 76.56% | Val Acc: 73.16%\n",
      "Epoch 24 | Train Acc: 77.79% | Val Acc: 73.55%\n",
      "Epoch 25 | Train Acc: 78.41% | Val Acc: 71.68%\n",
      "Epoch 26 | Train Acc: 78.96% | Val Acc: 72.96%\n",
      "Epoch 27 | Train Acc: 79.41% | Val Acc: 73.00%\n",
      "Epoch 28 | Train Acc: 79.93% | Val Acc: 73.20%\n",
      "Epoch 29 | Train Acc: 80.12% | Val Acc: 73.27%\n",
      "Epoch 30 | Train Acc: 81.64% | Val Acc: 74.75%\n",
      "Epoch 31 | Train Acc: 82.15% | Val Acc: 73.89%\n",
      "Epoch 32 | Train Acc: 81.32% | Val Acc: 72.81%\n",
      "Epoch 33 | Train Acc: 82.54% | Val Acc: 73.66%\n",
      "Epoch 34 | Train Acc: 82.66% | Val Acc: 72.96%\n",
      "Epoch 35 | Train Acc: 83.21% | Val Acc: 75.37%\n",
      "Epoch 36 | Train Acc: 83.18% | Val Acc: 75.21%\n",
      "Epoch 37 | Train Acc: 83.85% | Val Acc: 74.90%\n",
      "Epoch 38 | Train Acc: 84.33% | Val Acc: 74.94%\n",
      "Epoch 39 | Train Acc: 84.21% | Val Acc: 74.83%\n",
      "Epoch 40 | Train Acc: 85.16% | Val Acc: 73.86%\n",
      "Epoch 41 | Train Acc: 84.71% | Val Acc: 72.69%\n",
      "Epoch 42 | Train Acc: 84.35% | Val Acc: 75.56%\n",
      "Epoch 43 | Train Acc: 84.35% | Val Acc: 73.86%\n",
      "Epoch 44 | Train Acc: 85.74% | Val Acc: 76.07%\n",
      "Epoch 45 | Train Acc: 85.58% | Val Acc: 76.42%\n",
      "Epoch 46 | Train Acc: 85.19% | Val Acc: 76.73%\n",
      "Epoch 47 | Train Acc: 86.33% | Val Acc: 75.45%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 75.45%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.63      0.74      0.68       861\n",
      "           benigno       0.92      0.90      0.91       855\n",
      "carcinoma squamoso       0.74      0.62      0.67       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.76      0.75      0.76      2578\n",
      "      weighted avg       0.76      0.75      0.76      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 35.50% | Val Acc: 40.11%\n",
      "Epoch 02 | Train Acc: 52.61% | Val Acc: 49.65%\n",
      "Epoch 03 | Train Acc: 58.06% | Val Acc: 59.97%\n",
      "Epoch 04 | Train Acc: 60.22% | Val Acc: 59.81%\n",
      "Epoch 05 | Train Acc: 62.20% | Val Acc: 62.76%\n",
      "Epoch 06 | Train Acc: 62.83% | Val Acc: 63.03%\n",
      "Epoch 07 | Train Acc: 63.21% | Val Acc: 63.23%\n",
      "Epoch 08 | Train Acc: 63.40% | Val Acc: 64.90%\n",
      "Epoch 09 | Train Acc: 63.48% | Val Acc: 63.96%\n",
      "Epoch 10 | Train Acc: 64.28% | Val Acc: 64.04%\n",
      "Epoch 11 | Train Acc: 63.80% | Val Acc: 62.84%\n",
      "Epoch 12 | Train Acc: 64.56% | Val Acc: 66.14%\n",
      "Epoch 13 | Train Acc: 64.28% | Val Acc: 63.27%\n",
      "Epoch 14 | Train Acc: 64.52% | Val Acc: 68.27%\n",
      "Epoch 15 | Train Acc: 64.65% | Val Acc: 63.11%\n",
      "Epoch 16 | Train Acc: 64.83% | Val Acc: 64.78%\n",
      "Epoch 17 | Train Acc: 65.65% | Val Acc: 68.23%\n",
      "Epoch 18 | Train Acc: 65.63% | Val Acc: 69.20%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 69.20%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.56      0.57      0.56       862\n",
      "           benigno       0.92      0.91      0.91       854\n",
      "carcinoma squamoso       0.61      0.60      0.60       862\n",
      "\n",
      "          accuracy                           0.69      2578\n",
      "         macro avg       0.69      0.69      0.69      2578\n",
      "      weighted avg       0.69      0.69      0.69      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 37.77% | Val Acc: 47.81%\n",
      "Epoch 02 | Train Acc: 54.35% | Val Acc: 46.84%\n",
      "Epoch 03 | Train Acc: 58.73% | Val Acc: 59.06%\n",
      "Epoch 04 | Train Acc: 60.45% | Val Acc: 60.11%\n",
      "Epoch 05 | Train Acc: 61.81% | Val Acc: 59.57%\n",
      "Epoch 06 | Train Acc: 62.58% | Val Acc: 61.89%\n",
      "Epoch 07 | Train Acc: 63.47% | Val Acc: 61.97%\n",
      "Epoch 08 | Train Acc: 63.36% | Val Acc: 62.94%\n",
      "Epoch 09 | Train Acc: 64.86% | Val Acc: 63.21%\n",
      "Epoch 10 | Train Acc: 64.63% | Val Acc: 65.08%\n",
      "Epoch 11 | Train Acc: 63.87% | Val Acc: 61.54%\n",
      "Epoch 12 | Train Acc: 65.32% | Val Acc: 63.41%\n",
      "Epoch 13 | Train Acc: 65.22% | Val Acc: 66.20%\n",
      "Epoch 14 | Train Acc: 65.14% | Val Acc: 63.99%\n",
      "Epoch 15 | Train Acc: 65.55% | Val Acc: 64.77%\n",
      "Epoch 16 | Train Acc: 65.95% | Val Acc: 65.66%\n",
      "Epoch 17 | Train Acc: 65.23% | Val Acc: 67.13%\n",
      "Epoch 18 | Train Acc: 65.59% | Val Acc: 67.02%\n",
      "Epoch 19 | Train Acc: 67.39% | Val Acc: 68.10%\n",
      "Epoch 20 | Train Acc: 68.35% | Val Acc: 70.74%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 70.74%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.59      0.55      0.57       862\n",
      "           benigno       0.93      0.89      0.91       854\n",
      "carcinoma squamoso       0.62      0.68      0.65       861\n",
      "\n",
      "          accuracy                           0.71      2577\n",
      "         macro avg       0.71      0.71      0.71      2577\n",
      "      weighted avg       0.71      0.71      0.71      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 34.57% | Val Acc: 46.60%\n",
      "Epoch 02 | Train Acc: 47.02% | Val Acc: 51.18%\n",
      "Epoch 03 | Train Acc: 56.38% | Val Acc: 58.05%\n",
      "Epoch 04 | Train Acc: 59.54% | Val Acc: 59.64%\n",
      "Epoch 05 | Train Acc: 60.66% | Val Acc: 61.43%\n",
      "Epoch 06 | Train Acc: 62.07% | Val Acc: 63.72%\n",
      "Epoch 07 | Train Acc: 62.44% | Val Acc: 62.32%\n",
      "Epoch 08 | Train Acc: 63.45% | Val Acc: 63.91%\n",
      "Epoch 09 | Train Acc: 63.53% | Val Acc: 62.32%\n",
      "Epoch 10 | Train Acc: 64.23% | Val Acc: 68.57%\n",
      "Epoch 11 | Train Acc: 63.96% | Val Acc: 68.41%\n",
      "Epoch 12 | Train Acc: 65.38% | Val Acc: 64.07%\n",
      "Epoch 13 | Train Acc: 64.32% | Val Acc: 67.09%\n",
      "Epoch 14 | Train Acc: 65.48% | Val Acc: 66.16%\n",
      "Epoch 15 | Train Acc: 64.85% | Val Acc: 64.42%\n",
      "Epoch 16 | Train Acc: 65.08% | Val Acc: 69.38%\n",
      "Epoch 17 | Train Acc: 65.87% | Val Acc: 67.02%\n",
      "Epoch 18 | Train Acc: 67.07% | Val Acc: 70.86%\n",
      "Epoch 19 | Train Acc: 67.67% | Val Acc: 70.62%\n",
      "Epoch 20 | Train Acc: 68.06% | Val Acc: 68.92%\n",
      "Epoch 21 | Train Acc: 69.11% | Val Acc: 71.40%\n",
      "Epoch 22 | Train Acc: 69.45% | Val Acc: 71.98%\n",
      "Epoch 23 | Train Acc: 69.91% | Val Acc: 71.71%\n",
      "Epoch 24 | Train Acc: 70.88% | Val Acc: 72.25%\n",
      "Epoch 25 | Train Acc: 71.21% | Val Acc: 72.72%\n",
      "Epoch 26 | Train Acc: 72.15% | Val Acc: 73.42%\n",
      "Epoch 27 | Train Acc: 71.90% | Val Acc: 72.68%\n",
      "Epoch 28 | Train Acc: 74.15% | Val Acc: 73.38%\n",
      "Epoch 29 | Train Acc: 74.41% | Val Acc: 73.11%\n",
      "Epoch 30 | Train Acc: 74.87% | Val Acc: 73.11%\n",
      "Epoch 31 | Train Acc: 75.01% | Val Acc: 72.64%\n",
      "Epoch 32 | Train Acc: 74.70% | Val Acc: 73.38%\n",
      "Epoch 33 | Train Acc: 76.97% | Val Acc: 73.22%\n",
      "Epoch 34 | Train Acc: 75.72% | Val Acc: 74.04%\n",
      "Epoch 35 | Train Acc: 76.19% | Val Acc: 74.35%\n",
      "Epoch 36 | Train Acc: 77.93% | Val Acc: 74.74%\n",
      "Epoch 37 | Train Acc: 78.37% | Val Acc: 73.92%\n",
      "Epoch 38 | Train Acc: 77.49% | Val Acc: 75.36%\n",
      "Epoch 39 | Train Acc: 78.91% | Val Acc: 75.20%\n",
      "Epoch 40 | Train Acc: 79.08% | Val Acc: 75.09%\n",
      "Epoch 41 | Train Acc: 79.04% | Val Acc: 74.47%\n",
      "Epoch 42 | Train Acc: 79.33% | Val Acc: 73.15%\n",
      "Epoch 43 | Train Acc: 79.07% | Val Acc: 74.89%\n",
      "Epoch 44 | Train Acc: 80.55% | Val Acc: 75.67%\n",
      "Epoch 45 | Train Acc: 80.86% | Val Acc: 75.20%\n",
      "Epoch 46 | Train Acc: 80.80% | Val Acc: 75.13%\n",
      "Epoch 47 | Train Acc: 82.12% | Val Acc: 75.94%\n",
      "Epoch 48 | Train Acc: 81.28% | Val Acc: 75.82%\n",
      "Epoch 49 | Train Acc: 81.59% | Val Acc: 76.14%\n",
      "Epoch 50 | Train Acc: 82.46% | Val Acc: 75.86%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 75.86%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.62      0.81      0.70       862\n",
      "           benigno       0.94      0.91      0.92       854\n",
      "carcinoma squamoso       0.78      0.56      0.65       861\n",
      "\n",
      "          accuracy                           0.76      2577\n",
      "         macro avg       0.78      0.76      0.76      2577\n",
      "      weighted avg       0.78      0.76      0.76      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 13 - CV Mean Accuracy: 72.37% ¬± 2.74%\n",
      "\n",
      "[pca_data_2342_0.05] Config 14: {'hidden_dims': [1024, 512, 256], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [1024, 512, 256], 'batchnorm': True, 'dropout': 0.5, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 66.88% | Val Acc: 73.47%\n",
      "Epoch 02 | Train Acc: 76.14% | Val Acc: 74.36%\n",
      "Epoch 03 | Train Acc: 80.53% | Val Acc: 73.27%\n",
      "Epoch 04 | Train Acc: 84.42% | Val Acc: 73.74%\n",
      "Epoch 05 | Train Acc: 86.87% | Val Acc: 72.92%\n",
      "Epoch 06 | Train Acc: 89.38% | Val Acc: 75.14%\n",
      "Epoch 07 | Train Acc: 90.78% | Val Acc: 74.36%\n",
      "Epoch 08 | Train Acc: 92.05% | Val Acc: 76.03%\n",
      "Epoch 09 | Train Acc: 92.98% | Val Acc: 75.33%\n",
      "Epoch 10 | Train Acc: 93.62% | Val Acc: 75.64%\n",
      "Epoch 11 | Train Acc: 94.06% | Val Acc: 74.90%\n",
      "Epoch 12 | Train Acc: 94.61% | Val Acc: 76.03%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 76.03%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.69      0.68       861\n",
      "           benigno       0.87      0.93      0.90       855\n",
      "carcinoma squamoso       0.73      0.67      0.70       862\n",
      "\n",
      "          accuracy                           0.76      2578\n",
      "         macro avg       0.76      0.76      0.76      2578\n",
      "      weighted avg       0.76      0.76      0.76      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 66.45% | Val Acc: 72.61%\n",
      "Epoch 02 | Train Acc: 76.08% | Val Acc: 72.65%\n",
      "Epoch 03 | Train Acc: 81.17% | Val Acc: 74.59%\n",
      "Epoch 04 | Train Acc: 84.60% | Val Acc: 72.77%\n",
      "Epoch 05 | Train Acc: 87.54% | Val Acc: 72.85%\n",
      "Epoch 06 | Train Acc: 88.52% | Val Acc: 73.55%\n",
      "Epoch 07 | Train Acc: 91.08% | Val Acc: 73.51%\n",
      "Epoch 08 | Train Acc: 91.73% | Val Acc: 73.51%\n",
      "Epoch 09 | Train Acc: 92.78% | Val Acc: 73.66%\n",
      "Epoch 10 | Train Acc: 93.17% | Val Acc: 75.29%\n",
      "Epoch 11 | Train Acc: 93.95% | Val Acc: 73.58%\n",
      "Epoch 12 | Train Acc: 95.12% | Val Acc: 74.55%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 74.55%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.64      0.65       861\n",
      "           benigno       0.89      0.90      0.89       855\n",
      "carcinoma squamoso       0.68      0.70      0.69       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.74      0.75      0.75      2578\n",
      "      weighted avg       0.74      0.75      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 66.37% | Val Acc: 73.86%\n",
      "Epoch 02 | Train Acc: 76.60% | Val Acc: 73.24%\n",
      "Epoch 03 | Train Acc: 80.82% | Val Acc: 71.92%\n",
      "Epoch 04 | Train Acc: 84.41% | Val Acc: 73.62%\n",
      "Epoch 05 | Train Acc: 87.13% | Val Acc: 73.55%\n",
      "Epoch 06 | Train Acc: 89.27% | Val Acc: 73.89%\n",
      "Epoch 07 | Train Acc: 90.81% | Val Acc: 73.82%\n",
      "Epoch 08 | Train Acc: 91.61% | Val Acc: 74.17%\n",
      "Epoch 09 | Train Acc: 92.74% | Val Acc: 75.17%\n",
      "Epoch 10 | Train Acc: 93.33% | Val Acc: 74.05%\n",
      "Epoch 11 | Train Acc: 93.90% | Val Acc: 75.25%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 75.25%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.61      0.64       862\n",
      "           benigno       0.92      0.90      0.91       854\n",
      "carcinoma squamoso       0.68      0.75      0.71       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.75      0.75      0.75      2578\n",
      "      weighted avg       0.75      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 65.92% | Val Acc: 73.50%\n",
      "Epoch 02 | Train Acc: 76.53% | Val Acc: 72.91%\n",
      "Epoch 03 | Train Acc: 80.53% | Val Acc: 74.85%\n",
      "Epoch 04 | Train Acc: 84.35% | Val Acc: 72.72%\n",
      "Epoch 05 | Train Acc: 87.22% | Val Acc: 74.51%\n",
      "Epoch 06 | Train Acc: 88.98% | Val Acc: 74.08%\n",
      "Epoch 07 | Train Acc: 91.15% | Val Acc: 75.32%\n",
      "Epoch 08 | Train Acc: 92.59% | Val Acc: 75.32%\n",
      "Epoch 09 | Train Acc: 93.08% | Val Acc: 73.69%\n",
      "Epoch 10 | Train Acc: 93.31% | Val Acc: 75.09%\n",
      "Epoch 11 | Train Acc: 94.18% | Val Acc: 75.01%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 75.01%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.70      0.56      0.62       862\n",
      "           benigno       0.89      0.92      0.90       854\n",
      "carcinoma squamoso       0.66      0.77      0.71       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 66.40% | Val Acc: 72.37%\n",
      "Epoch 02 | Train Acc: 77.18% | Val Acc: 73.11%\n",
      "Epoch 03 | Train Acc: 81.38% | Val Acc: 72.45%\n",
      "Epoch 04 | Train Acc: 84.87% | Val Acc: 72.84%\n",
      "Epoch 05 | Train Acc: 87.31% | Val Acc: 74.00%\n",
      "Epoch 06 | Train Acc: 89.34% | Val Acc: 74.23%\n",
      "Epoch 07 | Train Acc: 91.01% | Val Acc: 73.77%\n",
      "Epoch 08 | Train Acc: 91.72% | Val Acc: 73.15%\n",
      "Epoch 09 | Train Acc: 92.94% | Val Acc: 74.39%\n",
      "Epoch 10 | Train Acc: 93.85% | Val Acc: 74.62%\n",
      "Epoch 11 | Train Acc: 94.70% | Val Acc: 74.70%\n",
      "Epoch 12 | Train Acc: 94.41% | Val Acc: 74.51%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.51%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.59      0.62       862\n",
      "           benigno       0.93      0.88      0.90       854\n",
      "carcinoma squamoso       0.66      0.77      0.71       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.74      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 14 - CV Mean Accuracy: 75.07% ¬± 0.55%\n",
      "\n",
      "[pca_data_2342_0.05] Config 15: {'hidden_dims': [1024, 512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üîÅ Cross-validation model: {'hidden_dims': [1024, 512, 256, 128, 64], 'batchnorm': True, 'dropout': 0.6, 'early_stopping': True, 'cross_val': True}\n",
      "\n",
      "üìÇ Fold 1/5\n",
      "Epoch 01 | Train Acc: 52.91% | Val Acc: 65.55%\n",
      "Epoch 02 | Train Acc: 63.71% | Val Acc: 68.58%\n",
      "Epoch 03 | Train Acc: 70.25% | Val Acc: 71.49%\n",
      "Epoch 04 | Train Acc: 73.54% | Val Acc: 72.23%\n",
      "Epoch 05 | Train Acc: 77.53% | Val Acc: 73.04%\n",
      "Epoch 06 | Train Acc: 79.35% | Val Acc: 74.40%\n",
      "Epoch 07 | Train Acc: 81.75% | Val Acc: 73.47%\n",
      "Epoch 08 | Train Acc: 83.66% | Val Acc: 75.29%\n",
      "Epoch 09 | Train Acc: 85.61% | Val Acc: 75.83%\n",
      "Epoch 10 | Train Acc: 86.24% | Val Acc: 75.68%\n",
      "Epoch 11 | Train Acc: 87.86% | Val Acc: 76.80%\n",
      "Epoch 12 | Train Acc: 89.18% | Val Acc: 76.18%\n",
      "Epoch 13 | Train Acc: 89.98% | Val Acc: 76.30%\n",
      "Epoch 14 | Train Acc: 90.57% | Val Acc: 76.03%\n",
      "Epoch 15 | Train Acc: 91.53% | Val Acc: 75.72%\n",
      "Epoch 16 | Train Acc: 92.13% | Val Acc: 76.61%\n",
      "Epoch 17 | Train Acc: 92.65% | Val Acc: 75.91%\n",
      "Epoch 18 | Train Acc: 93.13% | Val Acc: 75.72%\n",
      "Early stopping triggered.\n",
      "Fold 1 Accuracy: 75.72%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.68      0.65      0.66       861\n",
      "           benigno       0.87      0.94      0.90       855\n",
      "carcinoma squamoso       0.71      0.69      0.70       862\n",
      "\n",
      "          accuracy                           0.76      2578\n",
      "         macro avg       0.75      0.76      0.75      2578\n",
      "      weighted avg       0.75      0.76      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 2/5\n",
      "Epoch 01 | Train Acc: 53.37% | Val Acc: 64.62%\n",
      "Epoch 02 | Train Acc: 64.07% | Val Acc: 66.99%\n",
      "Epoch 03 | Train Acc: 69.70% | Val Acc: 70.87%\n",
      "Epoch 04 | Train Acc: 73.57% | Val Acc: 72.85%\n",
      "Epoch 05 | Train Acc: 76.72% | Val Acc: 72.54%\n",
      "Epoch 06 | Train Acc: 80.05% | Val Acc: 71.49%\n",
      "Epoch 07 | Train Acc: 81.41% | Val Acc: 73.04%\n",
      "Epoch 08 | Train Acc: 83.17% | Val Acc: 73.16%\n",
      "Epoch 09 | Train Acc: 85.28% | Val Acc: 72.96%\n",
      "Epoch 10 | Train Acc: 86.63% | Val Acc: 73.58%\n",
      "Epoch 11 | Train Acc: 87.68% | Val Acc: 73.24%\n",
      "Epoch 12 | Train Acc: 88.65% | Val Acc: 73.12%\n",
      "Epoch 13 | Train Acc: 89.83% | Val Acc: 73.35%\n",
      "Epoch 14 | Train Acc: 90.88% | Val Acc: 74.05%\n",
      "Early stopping triggered.\n",
      "Fold 2 Accuracy: 74.05%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.64      0.67      0.66       861\n",
      "           benigno       0.89      0.90      0.89       855\n",
      "carcinoma squamoso       0.69      0.66      0.67       862\n",
      "\n",
      "          accuracy                           0.74      2578\n",
      "         macro avg       0.74      0.74      0.74      2578\n",
      "      weighted avg       0.74      0.74      0.74      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 3/5\n",
      "Epoch 01 | Train Acc: 52.37% | Val Acc: 64.74%\n",
      "Epoch 02 | Train Acc: 64.29% | Val Acc: 70.02%\n",
      "Epoch 03 | Train Acc: 68.82% | Val Acc: 71.53%\n",
      "Epoch 04 | Train Acc: 72.72% | Val Acc: 73.08%\n",
      "Epoch 05 | Train Acc: 76.89% | Val Acc: 72.89%\n",
      "Epoch 06 | Train Acc: 79.42% | Val Acc: 71.96%\n",
      "Epoch 07 | Train Acc: 81.52% | Val Acc: 72.89%\n",
      "Epoch 08 | Train Acc: 83.39% | Val Acc: 73.58%\n",
      "Epoch 09 | Train Acc: 85.12% | Val Acc: 73.20%\n",
      "Epoch 10 | Train Acc: 85.84% | Val Acc: 73.58%\n",
      "Epoch 11 | Train Acc: 87.45% | Val Acc: 74.48%\n",
      "Epoch 12 | Train Acc: 88.35% | Val Acc: 75.25%\n",
      "Epoch 13 | Train Acc: 89.19% | Val Acc: 74.44%\n",
      "Epoch 14 | Train Acc: 90.60% | Val Acc: 74.17%\n",
      "Epoch 15 | Train Acc: 90.98% | Val Acc: 75.02%\n",
      "Early stopping triggered.\n",
      "Fold 3 Accuracy: 75.02%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.67      0.62      0.64       862\n",
      "           benigno       0.93      0.87      0.90       854\n",
      "carcinoma squamoso       0.67      0.76      0.71       862\n",
      "\n",
      "          accuracy                           0.75      2578\n",
      "         macro avg       0.76      0.75      0.75      2578\n",
      "      weighted avg       0.76      0.75      0.75      2578\n",
      "\n",
      "\n",
      "üìÇ Fold 4/5\n",
      "Epoch 01 | Train Acc: 54.24% | Val Acc: 64.42%\n",
      "Epoch 02 | Train Acc: 66.01% | Val Acc: 68.84%\n",
      "Epoch 03 | Train Acc: 70.86% | Val Acc: 72.60%\n",
      "Epoch 04 | Train Acc: 73.75% | Val Acc: 73.92%\n",
      "Epoch 05 | Train Acc: 76.95% | Val Acc: 74.08%\n",
      "Epoch 06 | Train Acc: 79.50% | Val Acc: 74.16%\n",
      "Epoch 07 | Train Acc: 81.69% | Val Acc: 73.07%\n",
      "Epoch 08 | Train Acc: 83.65% | Val Acc: 74.43%\n",
      "Epoch 09 | Train Acc: 85.58% | Val Acc: 74.04%\n",
      "Epoch 10 | Train Acc: 86.73% | Val Acc: 75.20%\n",
      "Epoch 11 | Train Acc: 87.86% | Val Acc: 75.40%\n",
      "Epoch 12 | Train Acc: 88.71% | Val Acc: 75.05%\n",
      "Epoch 13 | Train Acc: 89.99% | Val Acc: 75.28%\n",
      "Epoch 14 | Train Acc: 90.34% | Val Acc: 76.10%\n",
      "Epoch 15 | Train Acc: 91.16% | Val Acc: 76.25%\n",
      "Early stopping triggered.\n",
      "Fold 4 Accuracy: 76.25%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.63      0.66       862\n",
      "           benigno       0.89      0.93      0.91       854\n",
      "carcinoma squamoso       0.70      0.73      0.71       861\n",
      "\n",
      "          accuracy                           0.76      2577\n",
      "         macro avg       0.76      0.76      0.76      2577\n",
      "      weighted avg       0.76      0.76      0.76      2577\n",
      "\n",
      "\n",
      "üìÇ Fold 5/5\n",
      "Epoch 01 | Train Acc: 53.48% | Val Acc: 62.63%\n",
      "Epoch 02 | Train Acc: 66.08% | Val Acc: 69.89%\n",
      "Epoch 03 | Train Acc: 70.50% | Val Acc: 71.98%\n",
      "Epoch 04 | Train Acc: 74.71% | Val Acc: 72.25%\n",
      "Epoch 05 | Train Acc: 77.31% | Val Acc: 71.71%\n",
      "Epoch 06 | Train Acc: 79.82% | Val Acc: 72.18%\n",
      "Epoch 07 | Train Acc: 82.18% | Val Acc: 72.72%\n",
      "Epoch 08 | Train Acc: 84.04% | Val Acc: 72.41%\n",
      "Epoch 09 | Train Acc: 85.71% | Val Acc: 73.22%\n",
      "Epoch 10 | Train Acc: 86.66% | Val Acc: 72.60%\n",
      "Epoch 11 | Train Acc: 88.38% | Val Acc: 73.22%\n",
      "Epoch 12 | Train Acc: 89.27% | Val Acc: 73.77%\n",
      "Epoch 13 | Train Acc: 90.12% | Val Acc: 74.74%\n",
      "Epoch 14 | Train Acc: 90.48% | Val Acc: 74.74%\n",
      "Early stopping triggered.\n",
      "Fold 5 Accuracy: 74.74%\n",
      "                    precision    recall  f1-score   support\n",
      "\n",
      "    adenocarcinoma       0.69      0.56      0.62       862\n",
      "           benigno       0.92      0.91      0.92       854\n",
      "carcinoma squamoso       0.64      0.78      0.70       861\n",
      "\n",
      "          accuracy                           0.75      2577\n",
      "         macro avg       0.75      0.75      0.75      2577\n",
      "      weighted avg       0.75      0.75      0.75      2577\n",
      "\n",
      "\n",
      "‚úÖ Config 15 - CV Mean Accuracy: 75.16% ¬± 0.77%\n"
     ]
    }
   ],
   "source": [
    "for i, config in enumerate(configurations, 1):\n",
    "    print(f\"\\n[{experiment_name}] Config {i}: {config}\")\n",
    "    if config.get(\"cross_val\", False):\n",
    "        cross_validate_model(config, torch.cat([X_train, X_val]), torch.cat([y_train, y_val]), k=5, config_id=i)\n",
    "    else:\n",
    "        model = FlexibleNet(n_components, config['hidden_dims'], len(pretty_labels),\n",
    "                            use_batchnorm=config['batchnorm'], dropout=config['dropout'])\n",
    "        criterion = nn.CrossEntropyLoss()\n",
    "        optimizer = optim.Adam(model.parameters(), lr=0.001, weight_decay=1e-4)\n",
    "\n",
    "        model, history = train_model(model, train_loader, val_loader, criterion, optimizer,\n",
    "                                     use_early_stopping=config['early_stopping'])\n",
    "\n",
    "        model.eval()\n",
    "        y_true, y_pred = [], []\n",
    "        with torch.no_grad():\n",
    "            for X_batch, y_batch in test_loader:\n",
    "                output = model(X_batch)\n",
    "                preds = output.argmax(1)\n",
    "                y_true.extend(y_batch.tolist())\n",
    "                y_pred.extend(preds.tolist())\n",
    "\n",
    "        test_acc = 100 * np.mean(np.array(y_true) == np.array(y_pred))\n",
    "        precision = precision_score(y_true, y_pred, average='macro')\n",
    "        recall = recall_score(y_true, y_pred, average='macro')\n",
    "        f1 = f1_score(y_true, y_pred, average='macro')\n",
    "        report_txt = classification_report(y_true, y_pred, target_names=pretty_labels)\n",
    "        cm = confusion_matrix(y_true, y_pred)\n",
    "        specificity_macro = specificity_score(y_true, y_pred, average='macro')\n",
    "        specificity_per_class = specificity_score(y_true, y_pred, average='none')\n",
    "\n",
    "        print(report_txt)\n",
    "        print(\"Confusion Matrix:\")\n",
    "        print(cm)\n",
    "        print(f\"Specificity (macro): {specificity_macro:.4f}\")\n",
    "        for label, spec in zip(pretty_labels, specificity_per_class):\n",
    "            print(f\"Specificity [{label}]: {spec:.4f}\")\n",
    "\n",
    "        title = f\"[{experiment_name}] Config {i}\"\n",
    "        with open(log_txt_path, \"a\") as f:\n",
    "            f.write(f\"{title}\\nTest Accuracy: {test_acc:.2f}%\\n\")\n",
    "            f.write(report_txt + \"\\n\")\n",
    "            f.write(\"Confusion Matrix:\\n\" + np.array2string(cm) + \"\\n\")\n",
    "            f.write(\"Specificities:\\n\")\n",
    "            for label, spec in zip(pretty_labels, specificity_per_class):\n",
    "                f.write(f\"{label}: {spec:.4f}\\n\")\n",
    "            f.write(\"=\"*80 + \"\\n\")\n",
    "\n",
    "        plt.figure(figsize=(8, 6))\n",
    "        sns.heatmap(cm, annot=True, fmt='d', xticklabels=pretty_labels, yticklabels=pretty_labels, cmap='Blues')\n",
    "        plt.title(f\"{title} - Confusion Matrix\")\n",
    "        plt.xlabel('Predicted')\n",
    "        plt.ylabel('True')\n",
    "        plt.tight_layout()\n",
    "        plt.savefig(os.path.join(\"pca_outputs\", f\"{experiment_name}_conf_matrix_config_{i}.png\"))\n",
    "        plt.show()\n",
    "\n",
    "        summary.append({\n",
    "            'config_id': i,\n",
    "            'hidden_dims': config['hidden_dims'],\n",
    "            'dropout': config['dropout'],\n",
    "            'batchnorm': config['batchnorm'],\n",
    "            'early_stopping': config['early_stopping'],\n",
    "            'cross_val': False,\n",
    "            'accuracy': test_acc,\n",
    "            'precision': precision,\n",
    "            'recall': recall,\n",
    "            'f1_score': f1,\n",
    "            'specificity': specificity_macro,\n",
    "            'specificity_per_class': specificity_per_class,\n",
    "            'conf_matrix': cm.tolist()\n",
    "        })"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "a188680b",
   "metadata": {},
   "outputs": [],
   "source": [
    "summary_df = pd.DataFrame(summary)\n",
    "summary_df.to_csv(os.path.join(\"pca_outputs\", f\"{experiment_name}_summary.csv\"), index=False)\n",
    "\n",
    "with open(os.path.join(\"pca_outputs\", f\"{experiment_name}_summary.txt\"), 'w') as f:\n",
    "    for row in summary:\n",
    "        f.write(f\"Config {row['config_id']} | Acc: {row['accuracy']:.2f}% | Dropout: {row['dropout']} | Layers: {row['hidden_dims']}\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "5d1237f2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Index(['config_id', 'hidden_dims', 'dropout', 'batchnorm', 'early_stopping',\n",
      "       'cross_val', 'accuracy', 'precision', 'recall', 'f1_score',\n",
      "       'conf_matrix'],\n",
      "      dtype='object')\n"
     ]
    }
   ],
   "source": [
    "print(summary_df.columns)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "a6be7dd1",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1600x700 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# plot confronto metriche diversi reti\n",
    "bar_width = 0.16  # ridotto per far entrare 5 metriche\n",
    "x = np.arange(len(summary_df))\n",
    "\n",
    "\n",
    "plt.figure(figsize=(16, 7))\n",
    "plt.bar(x - 2 * bar_width, summary_df['accuracy']/100, width=bar_width, label='Accuracy', color='#7F8C8D')     # grigio\n",
    "plt.bar(x - 1 * bar_width, summary_df['precision'], width=bar_width, label='Precision', color='#F1C40F')     # oro pallido\n",
    "plt.bar(x, summary_df['recall'], width=bar_width, label='Recall', color='#3498DB')                           # blu pastello\n",
    "plt.bar(x + 1 * bar_width, summary_df['f1_score'], width=bar_width, label='F1 Score', color='#9B59B6')       # lilla soft\n",
    "plt.bar(x + 2 * bar_width, summary_df['specificity'], width=bar_width, label='Specificity', color='#95A5A6')  # grigio chiaro\n",
    "\n",
    "\n",
    "plt.xlabel(\"Modelli\")\n",
    "plt.ylabel(\"Valore (0-1)\")\n",
    "plt.title(f\"Confronto metriche per Configurazione - PCA {n_components}_{noise_std}\")\n",
    "plt.xticks(x, [f\"Modello {cid}\" for cid in summary_df['config_id']], rotation=45)\n",
    "plt.ylim(0.7, 0.78)\n",
    "plt.legend()\n",
    "plt.yticks(np.arange(0.7, 0.78, 0.01))  # ogni 0.01 tra 0.7 e 0.8\n",
    "plt.grid(axis='y', linestyle='--', alpha=0.6)\n",
    "plt.tight_layout()"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "base",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
